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Abstract 
 For the past ten years, a growing spread of new psychoactive 
substances (NPS) has been witnessed worldwide. In order to circumvent 
existing narcotics and psychotropic substances legislations, these compounds 
have been traditionally sold as innocuous products, advertised as being herbal 
incenses, plant feeders or bath salts, in smartshops or over the Internet. 
 The rapidly growing problem of NPS makes international control a real 
challenge, with the traditional detection methods becoming increasingly 
inadequate. In Portugal, the identification of these compounds became more 
important with the implementation of a new decree in 2013 (Dec-Lei 54/2013, of 
17th of April), which forbids the production and commercialisation of about 159 
NPS, being liable to fast updates. In order to create effective analytical 
databases to facilitate the identification of these drugs in Portugal, a 
collaboration was established between Faculdade de Ciências da Universidade 
de Lisboa (FCUL) and the Laboratório de Polícia Científica da Polícia Judiciária 
(LPC/PJ). With the decree, more than 34000 products that were sold in 8 
Portuguese smartshops were delivered to LPC/PJ. From those, two types of 
products, plant feeders and herbal incenses, known to contain two of the most 
reported categories of NPS, synthetic cathinones and synthetic cannabinoids, 
were selected for analyses. The plant feeders and herbal incenses were 
analysed in order to create an in-house Gas Chromatography-Electron Impact-
Mass Spectrometry (GC-EI-MS) library of NPS, as their characterisation and 
structural elucidation by Nuclear Magnetic Resonance Spectroscopy (NMR) will 
allow their use as secondary standards in routine GC-MS analysis at LPC/PJ. 
In this project, the methanolic extracts of 169 samples (111 plant feeders, 
56 herbal incenses and 5 seized products) were studied. The identification of 26 
NPS (12 synthetic cathinones, 12 synthetic cannabinoids, 5-MeO-DALT and 
ethylphenidate) was achieved by EI-MS fragmentation patterns of all the 
compounds and NMR characterisation of mephedrone, ethylphenidate, JWH-
018, JWH-122, JWH-210 and SGT-25. EI-MS was based on the characteristic 
fragments of each compound and NMR was based on one and two-dimensional 
experiments. This study led to the unequivocal identification of 21 secondary 
standards that allowed the creation of an in-house library of NPS. 
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The first batch of secondary standards analysed by GC-EI-MS in LPC/PJ 
were 8 plant feeders and two synthetic compounds that contained 10 
cathinones (3,4-DMMC, 4-MEC, buphedrone, flephedrone, MDBPB, MDPV, 
methedrone, methylone, N-ethylcathinone and pentedrone) explicitly identified 
in FCUL by NMR and GC-EI-MS previously in this project. This EI-MS library 
was used in the study of 103 plant feeders with 15 different brand names and 
16 different lot numbers, as to assess their qualitative and quantitative variability 
within lots and brand names. Buphedrone and MDPBP were not detected in 
these samples, but a compound not yet present in the library was detected, 
ethylphenidate. In some of those plant feeders, caffeine was also detected. 
Analysis of previous results from seized plant feeders analysed at LPC/PJ in 
2011 permitted the inclusion of mephedrone in the database, after 
confirmational analysis by NMR. 
In the GC-EI-MS analyses of 53 herbal incenses, 11 synthetic 
cannabinoids, one cathinone (MDPV), Vitamin E, caffeine and a tryptamine 
derivative, 5-Meo-DALT, were identified. Seven out of the eleven detected 
cannabinoids were isolated from herbal incenses (JWH-018, JW-122 and JWH-
210 in this project). All the 7 purified cannabinoids (JWH-018, JWH-122, JWH-
210, AKB48, UR-144, XLR-11 and MAM2201) were clearly identified by NMR 
permitting their use as secondary standards. 
The developed methodology was applied in 4 seized samples, allowing 
the identification of two NPS not included in the library: SGT-25, a synthetic 
cannabinoid recently reported in the European Union (EU); and 4F-PBP, a 
novel synthetic cathinone in the EU reported by us during this project. 
 This project allowed the construction of an in-house GC-EI-MS library of 
synthetic NPS, comprising 21 compounds in total: 12 cathinones (3,4-DMMC, 
4F-PBP, 4-MEC, buphedrone, flephedrone, MDBPB, MDPV, mephedrone, 
methedrone, methylone, N-ethylcathinone and pentedrone), 8 cannabinoids 
(AKB48, JWH-018, JWH-122, JWH-210, MAM2201, UR-144, SGT-25 and XLR-
11) and ethylphenidate. 
Keywords: GC-EI-MS library; NMR; Synthetic Cathinones; Synthetic 
Cannabinoids; NPS  
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Resumo 
Nos últimos anos tem-se verificado uma crescente propagação de novas 
substâncias psicoativas (NSP) em todo o mundo. Só na Europa, em 2014, mais 
de 100 novas NSP foram reportadas. NSP são definidas pelo Conselho 
Europeu como “substâncias em estado puro ou numa preparação que podem 
constituir uma ameaça à saúde pública comparável às substâncias listadas nas 
convenções das Nações Unidas”. Estes compostos têm sido tradicionalmente 
vendidos em smartshops ou na Internet como produtos inócuos, anunciados 
como sendo incensos herbais, fertilizantes para plantas ou sais de banho, 
sempre com a informação de que não se destinam ao consumo humano. 
O problema do rápido desenvolvimento destas substâncias cria grandes 
desafios ao nível do controlo internacional, em que as metodologias 
tradicionais de análise mostram-se, por vezes, insuficientes face a estes novos 
compostos. Em Portugal, a identificação de NSP ganhou especial relevo com a 
entrada em vigor do Decreto-Lei 54/2013, de 17 de Abril, que proíbe, entre 
outros, a produção e comercialização de cerca de 159 NSP, sendo passível de 
rápidas atualizações, de modo a manter-se a par com o diário aparecimento de 
novas substâncias. Em Junho de 2014, um protocolo foi assinado entre a 
Faculdade de Ciências da Universidade de Lisboa (FCUL), o Laboratório de 
Polícia Científica da Polícia Judiciária (LPC/PJ) e a Faculdade de Farmácia da 
Universidade do Porto (FFUP), com o objetivo de criar bases de dados eficazes 
de modo a facilitar a identificação deste tipo de compostos em Portugal e 
avaliar a sua toxicidade. 
 Este trabalho consistiu na análise de incensos herbais e fertilizantes 
para plantas de 8 smartshops da Área Metropolitana de Lisboa, entregues 
voluntariamente aquando da entrada em vigor do Decreto-Lei 54/2013 ou de 
produtos apreendidos. A metodologia desenvolvida neste trabalho consiste na 
análise destes produtos por Cromatografia Gasosa acoplada à Espectrometria 
de Massa (GC-MS) e Espetroscopia de Ressonância Magnética Nuclear 
(RMN), com o objetivo de caracterizar os compostos presentes e permitir o seu 
uso enquanto padrões qualitativos secundários em análises de rotina por GC-
MS no LPC/PJ. 
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 Uma compilação dos produtos de acordo com a smartshop de origem, o 
nome do produto e o lote permitiu aferir que no total, 34649 produtos foram 
entregues voluntariamente. Destes, 6374 eram fertilizantes para plantas em pó 
e 15177 eram incensos herbais. 
 Fertilizantes para plantas e incensos herbais têm, geralmente, na sua 
constituição, catinonas sintéticas e canabinóides sintéticos, duas das 
categorias de compostos mais reportadas no espaço europeu. 
 Inicialmente, 8 fertilizantes para plantas e 2 produtos de síntese 
previamente analisados por GC-MS e RMN na FCUL, foram analisados por 
GC-EI-MS no LPC/PJ, permitindo a construção de uma primeira biblioteca de 
espectros de massa com 10 catinonas sintéticas: 3,4-DMMC, 4-MEC, 
bufedrona, flefedrona, MDBPB, MDPV, metedrona, metilona, N-etilcatinona e 
pentedrona. Esta análise permitiu a caracterização de fragmentos mássicos 
característicos para cada composto e para substituições características e 
passíveis de ocorrerem neste tipo de compostos. De modo a caracterizar 
qualitativa e quantitativamente fertilizantes para plantas vendidos em Portugal 
com o mesmo nome e o mesmo número de lote, 103 fertilizantes para plantas 
com 15 nomes diferentes (Blast, Bliss, Bloom, Blow, Charlie, Crabby, Cyclop, 
Darko, Demon, E.T., Kick, Mush, Rush, The Cannon, Vamp) e 16 números de 
lote distintos, foram analisados, sendo a sua identificação baseada na 
comparação com a base de dados criada. Verificou-se uma uniformidade 
qualitativa dos produtos, no que ao número de lote diz respeito. Das 10 
catinonas presentes na biblioteca, não foram detetadas a bufedrona e a 
MDPBP nestes lotes de amostras. Desta análise, detetou-se um composto que 
não constava da base de dados in-house, cuja análise por GC-MS sugeriu 
tratar-se do etilfenidato. A sua análise por RMN permitiu a caracterização 
estrutural do composto, confirmando a identificação efectuada por 
espectrometria de massa. Em alguns dos fertilizantes, foi também detetada a 
cafeína, um adulterante comum neste tipo de produtos. 
Com o intuito de obter mais padrões secundários de NSP, fez-se um 
levantamento de resultados de análises a fertilizantes para plantas realizados 
no LPC em 2011. Uma amostra do fertilizante para plantas “Blow”, cuja análise 
por GC-MS revelou a presença de mefedrona, foi analisada por RMN, que 
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confirmou a identificação realizada e permitiu a inclusão deste composto na 
base de dados. 
 Uma análise preliminar por GC-MS de 33 incensos herbais (2012, 
Algerian Blend, Apple, Atomic Bomb, Blow, Bombastic Kaboom Spliff Atomic 
Bomb, B.R.O.S., Buddah, Butterfly, Caramba, Cheese, Esfinge, Freemind, 
Future, Home Run, Kaboom, Magic, Mandala, MÁUI, Maya2012, Planet H, 
PUM!, Radioactive, Rainbow, Red Sunshine, Royal Mix, Smoke, So High, 
Spike99, Spliff, T-Rex, The Unicorn, Tornado, Whacked), permitiu a 
identificação, por comparação com a biblioteca de espectros SWGDRUG, de 
10 canabinóides sintéticos (JWH-018, JWH-122, JWH-210, JWH-250, 
MAM2201, AKB48, UR-144, AM694, AM684-derivado cloro e AM1248). Um 
estudo das fragmentações de massa de cada composto possibilitou aferir 
fragmentações características para diferentes grupos estruturais, permitindo 
uma futura análise mais simplificada destes compostos. Uma segunda análise 
por GC-MS foi realizada em incensos herbais, de modo a seleccionar produtos 
para isolamento dos compostos da matriz herbal por cromatografia líquida e 
sua caracterização por RMN, de modo a obter o maior número de padrões 
secundários possível. Desta análise identifcou-se um outro composto, XLR-11 
(derivado fluorado do UR-144). Neste âmbito, foram isolados da matriz por 
cromatografia líquida, e analisados por RMN, 7 canabinóides sintéticos JWH-
018, JWH-122, JWH-210, AKB48, UR-144, XLR-11 e MAM2201, que foram 
usados para a construção de uma base de dados in-house para canabinóides 
sintéticos. 
A relevância da base de dados criada foi comprovada com a 
identificação de uma nova NPS nunca antes reportada no espaço europeu, 4F-
PBP. A presença de fragmentações de massa características permitiu a 
sugestão de uma estrutura para o composto, que foi elucidada por RMN, 
permitindo a inequívoca identificação desta nova catinona sintética. A análise 
por RMN permitiu ainda a deteção de um outro composto, mio-inositol, não 
detetado por GC-MS. A construção desta base de dados permitiu a 
identificação de um novo composto, que, aquando da altura da análise, ainda 
não se encontrava presente nas bibliotecas de espectros de massa existentes 
no LPC/PJ. O composto foi analisado por GC-MS e RMN, tendo sido 
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identificado como tratando-se do SGT-25, um canabinóide sintético 
recentemente reportado na Europa. A escassez de dados analíticos deste 
composto levou ao seu estudo de fragmentações mássicas e análise por NMR 
em diferentes solventes, CDCl3, MeOD, DMSO e benzeno (d6). 
 Este trabalho permitiu a construção de uma biblioteca de espectros de 
massa e tempos de retenção in-house composta por 21 compostos sintéticos: 
12 catinonas sintéticas (3,4-DMMC, 4F-PBP, 4-MEC, bufedrona, flefedrona, 
MDPBP, MDPV, mefedrona, metedrona, metilona, N-etilcatinona e 
pentedrona), 8 canabinóides sintéticos (JWH-018, JWH-122, JWH-210, AKB48, 
UR-144, MAM2201, XLR-11 e SGT-25) e o etilfenidato (Figura 1). Estes 
resultados comprovam a aplicabilidade da metodologia proposta neste trabalho 
na análise de NPS, permitindo uma mais fácil e mais eficaz análise de rotina 
por parte de um laboratório forense, cuja resposta quer-se rápida e adequada 
ao fim a que se destina. 
 
 
Figura 1 - Biblioteca de EI-MS de Catinonas Sintéticas e Canabinóides Sintéticos 
Palavras-chave: Biblioteca GC-EI-MS; NMR; Catinonas Sintéticas; 
Canabinóides Sintéticos 
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1. Introduction 
1.1. NPS – a worldwide phenomenon 
According to the United Nations Office on Drugs and Crime (UNODC) [1] 
and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
[2], based on the Council Decision 2005/387/JHA of 10th May 2005 on the 
information exchange, risk-assessment and control of new psychoactive 
substances (Council Decision) [3], a New Psychoactive Substance (NPS) is a 
“substance of abuse, either in a pure form or preparation, that is not controlled 
by the 1961 Convention of Narcotic Drugs or the 1971 Convention on 
Psychotropic Substances, but which may pose a public health threat”. 
Therefore, when using the term NPS, one should not be biased to believe that 
these substances have been recently developed. On the contrary, most of these 
substances have been synthesised in the 1970’s, some even earlier, intended 
for medical use; however, their chemistry has been slightly altered in order to 
produce similar effects to those caused by known illicit drugs [1], [4]. 
The phenomenon of NPS in not a new trend per se. What is meant is that 
the use of novel substances in order to circumvent existing legislation started in 
the 1980’s with the so-called designer drugs, which have been defined by the 
International Narcotics Control Board (INCB) as “substances that have been 
developed especially to avoid existing drug control measures”, referring to 
drugs produced from chemical precursors in clandestine laboratories or referred 
to as “research chemicals” [5]. The nomenclature of new substances appearing 
in illicit market has been evolving since then, going from “club drugs” to “legal 
highs” and “research chemicals” [6]. Of course, nowadays the most correct 
name in NPS. 
There are different types of NPS. The European Police Office (Europol) and the 
EMCDDA have differentiated them according to their production, marketing and 
supply [4]. In 2012, 6 different groups of substances were defined as NPS: 
phenethylamines, tryptamines, piperazines, synthetic cathinones, synthetic 
cannabinoids and other substances that do not fall within any of the categories 
mentioned before [6]. However, from 2005 and up to the end of 2014, more 
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than 450 NPS have been reported in the European Union (EU), thus creating 
the need to have more classes of these substances (Figure 1). Hence, in the 
end of 2014, 3 more categories were considered by the EMCDDA: 
benzodiazepines, arylamines and opioids [7]. 
 
Figure 1 - NPS reported in Europe from 2005 to 2014 [7] 
Also, by analysing the graphic in Figure 1, the most reported classes of 
NPS are synthetic cannabinoids and synthetic cathinones. Just in 2014, this two 
groups of substances accounted for approximately 50% of the total NPS 
reported in the EU. Data from 2014 reveals that, from 2008, 81 synthetic 
cathinones and 134 synthetic cannabinoids have been reported in Europe [8]. 
 Reports suggest that synthetic cathinones and synthetic cannabinoids 
are usually sold as harmless plant feeders and herbal incenses, respectively [9, 
2, 10] 
1.2. EU Control of NPS and the Portuguese Legislation 
At the end of the first decade of the 21st century, after a rapid emergence 
of NPS, governments, not only in Europe, but all over the world, where faced 
with the problem on how to legislate these new substances, some even 
considering if there was a real need to control them [11]. Having said that, 
governments tried to tackle the problem by creating national or regional 
legislation, with the goal to overcome the concerns related to the risks that 
these substances could present to public health [1]. 
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Regionally, the most interesting case is the EU case. In 2005, Council 
Decision 2005/387/JHA was adopted in order to create a general procedure to 
be used by all Member States and which main focus is the assessment and 
rapid communication of the risks associated with NPS [1]. Basically, this is 
achieved in a three-step approach [2]: 
a) Information exchange/ early warning 
b) Risk assessment 
c) Decision-making 
The first approach culminates in a Joint Report by the EMCDDA and 
Europol that is created when it is considered that information gathered by 
Member States on the detection, manufacture, traffic or use of a NPS justifies a 
follow-up. This report is submitted to the Council of the EU, the European 
Commission and the European Medicines Agency (EMEA); 
The Risk assessment is conducted by the scientific committee of 
EMCDDA and presented to the Commission and the Council when, by decision 
of the Council or the European Commission, it is considered that further 
assessment on the health and social possible problems associated with a newly 
identified substance is needed. 
Finally, on the basis of the risk assessment, it may be decided by the 
Council of the EU that a new substance needs to go under control measures. 
These are defined by the Member States in line with their national legislation, 
which abide by the UN Conventions.  
It should be noted that when a Member State considers it is relevant to 
control a substance at a national level that has not been assessed in the same 
way by the Council, it has the independence to do so [1], [2], [3], [4]. 
Up to this date, 11 joints reports (6 of which in 2014) and 7 risk 
assessments have been published under the terms of the Council Decision. 
Across the EU, different innovative legal responses have been created in 
order to control the open sale of these substances [12]. 
Basically, they can be differentiated in three different types of response, 
as follows: a) Controls using consumer safety or medicines legislation (Poland 
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and the UK, for example); b) Extending and adapting existing laws and 
processes (France and Italy, for example); and c) Devising new legislation to 
tackle new substances (Romania and Ireland, for example) [12]. 
In Portugal, the approach was to create new legislation under which 
these NPS would be controlled, without changing already drug control 
legislation. 
Hence, on the 17th April 2013, a new Decree-Law was published in Diário 
da República, in order to control the production, importation, exportation, 
advertisement, distribution, sale, possession and provision of NPS (Dec Lei 
54/2013, of 17th April) [13]. This new decree did not bring any changes to the 
already existing law that controls the trafficking and possession of illicit drugs in 
Portugal (Dec Lei 15/1993, of 22nd January) [14]. 
1.3. Plant Feeders 
Synthetic cathinones are one of the most reported classes of NPS. Just 
in 2014, 31 new synthetic cathinone were reported to the EWS [7]. These 
psychoactive compounds are usually sold covertly as plant feeders or bath 
salts. Plant Feeders are one of the most commonly found products in smart 
shops or ‘head shops’. Their intended use is snorting or ingestion, although 
recently there have been reports of their use as injection drugs [15]. 
 
Figure 2 - Example of Plant Feeders from Portuguese Smart shops 
The marketing on the packages was very smart and interesting. As seen 
in Figure 2, the packages were very appealing, with bright colours and 
suggestive names, often giving a hint on what to expect from consuming the 
product (for example, product named “Rush”). 
Another interesting fact on these packages is their back label. Figure 3 
shows a commonly found label in these products. It lists ingredients and mode 
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of use. The ingredients list often consists of ketones and caffeine. The curious, 
though, is the mode of use. It is suggested that the recommended dosage 
should not be exceeded, unless the product is being applied on a large (i.e. 
adult) plant. The term large or adult may be indicative of the adult’s only use of 
these products. 
 
Figure 3 - Back Label of Plant Feeders 
These type of products are usually presented in white powders or pills 
and intake modes include snorting or injection [16], which has become a serious 
problem in the EU and object of study by the EMCDDA [15]. Literature suggests 
that when plant feeders come in powdered form, they usually consist of 
synthetic cathinones, one of the main classes of NPS [17], [18]. 
Synthetic cathinones can be considered structural derivatives of the 
natural occurring product from the leaves of the Khat plant (Catha edulis), 
cathinone (Figure 4) [19]. The use of this plant for its stimulating effects is 
common practice in Eastern and Central African and Middle Eastern countries 
[16]. These psychoactive effects are similar to those provoked by 
amphetamines [20], generally behaving as central nervous system (CNS) 
stimulants [21].  
 
Figure 4 - Chemical Structure of Cathinone 
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Cathinone derivatives first appeared in the European market in the mid-
2000s [22], but their synthesis has been reported since the 1920s, mainly 
investigated for medical purposes, but most of them have rapidly been 
discarded of their intended use due to severe side effects [20]. 
 Synthetic cathinones are β-keto analogues of amphetamines, and their 
basic structure (Figure 5) can be altered in different ways, hence several 
variations can occur in the same derivative, making it possible to have dozens 
of different compounds considered synthetic cathinones [16], [9]. 
 
Figure 5 - General Chemical Structure of Synthetic Cathinones 
For example, additional functionality may be added in the aromatic ring, 
either with alkyl groups or halogens (R4); different substituents at the α-carbon 
(R3 and/or R5), usually with an alkyl group, or N-alkylation (more common, but 
the nitrogen atom may also be part of a ring structure, mainly pyrrolidine). 
Up to 2014, 81 synthetic cathinones have been reported through the EU 
EWS. However, just in 2014, 32 novel cathinone derivatives were reported. [7]. 
 Cathinone is already listed in the international drug control conventions. 
Also, in March 2015, mephedrone, methylone and MDPV (Figure 6) were 
included in the schedules of the international conventions. 
 
Figure 6 – Synthetic Cathinones recently added to the International Conventions 
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1.4. Herbal Incenses 
Synthetic cannabinoids are usually sold in an herbal mixture, advertised 
as herbal incenses, as a smoking product. Like plant feeders, herbal incenses 
are one of the most widespread products sold on the ‘legal highs’ market. Their 
popularity was not immediate, being initially used only amongst experimental 
users. However, reports on the use of these substances as legal substitutes of 
cannabis and user’s perspectives on online forums increased their popularity 
[10]. The marketing used for plant feeders was also applied to herbal incenses, 
making them especially appealing to young users (Figure 7). 
 
Figure 7 - Example of Herbal Incenses from Portuguese Smart shops 
These type of products started appearing in the EU market circa 2004, 
when herbal mixtures were being sold under the name “Spice” [10]. However, 
their popularity as ‘legal’ substituents of cannabis only reached high marks 
around 2008. After this increase in popularity, the first analytical data of these 
products was available, from different countries like Germany [23] or Japan [24]. 
These initial analyses revealed the presence of synthetic cannabinoids, or 
cannabimimetics, added to innocuous herbal mixtures. Unlike synthetic 
cathinones, that structurally derive from a parent compound and are all similar 
in structure, compounds classified as synthetic cannabinoids are so, because 
they are compounds with certain structural features that allow them to bind to 
one of the cannabinoids receptors present in the human brain, CB1 and CB2 
[10], therefore mimicking the effects of classical cannabinoids, such as Δ9-THC 
(Δ9-tetrahydrocannabinol). Structurally, synthetic cannabinoids are very 
different, as seen in the comparison of Δ9-TCH and JWH-018, the first synthetic 
cannabinoid to be reported to the EU EWS(Figure 8). 
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Figure 8 - Chemical structures of Δ9-THC and JWH-018 
The structural features of synthetic cannabinoids allow for a generic 
‘structure’, as seen in Figure 9. 
 
Figure 9 - Structural features of Synthetic Cannabinoids 
 Based on this generic structure, according to the EMCDDA, there are 
nowadays 14 chemical families of synthetic cannabinoids [25]. These ‘families’ 
are classified according to the core and ring structures of the compounds. 
Although the number of families is quite large, most reported compounds 
belong either to the naphthoylindole or the benzoylindole families [26]. Since the 
reporting of JWH-018, more 133 synthetic cannabinoids have been reported 
until the end of 2014. A major increase was observed in 2011, when synthetic 
cannabinoids more than doubled. In 2014 alone, 30 synthetic cathinones were 
reported to the EU EWS (Figure 10) [7], [25]. 
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Figure 10 - Number of Synthetic Cannabinoids reported to the EWS 2009-2014 
1.5. Objectives/Scope 
This work was developed within the protocol established between FCUL, 
LPC/PJ and FFUP, following the implementation of the new legislation in 
Portugal, with which became necessary for the LPC to have the necessary 
analytical standards to analyse products that may appear within their case work. 
Therefore, the goal of this project is to develop an adequate analytical 
methodology that allows the rapid identification of new emerging drugs of abuse 
from different products with different matrices, even in the absence of analytical 
standards. Thus, these analytical standards will be obtained either by synthesis 
or by purification of products from the voluntary deliveries or seized products, 
using Nuclear Magnetic Resonance Spectroscopy (NMR) as a tool to 
structurally characterise the products in order to use them as standards for 
other analytical techniques, such as Gas Chromatography-Mass Spectrometry 
(GC-MS). In the case of the herbal incenses, NMR identification is performed 
after isolation from the herbal matrix. 
Hence, this analytical strategy is based on the premises recommended 
by the Scientific Working Group for the Analysis of Seized Drugs 
(SWGDRUGS) in their 2014 Recommendations [27]. 
In their booklet, they recommend the minimum standards for the forensic 
identification of drugs of abuse in seized products. The use of uncorrelated 
techniques is advised, suggesting that when a Category A technique is used, 
one other technique, from any category, can used (Table 1). 
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Table 1 - Categories of Analytical Techniques according to the SWGDRUGS [27], page 14 
Category A Category B Category C 
Infrared Spectroscopy Capillary Electrophoresis Ultraviolet Spectroscopy 
Mass Spectrometry Gas Chromatography Colour Tests 
NMR Spectroscopy Liquid Chromatography Immunoassay 
Raman Spectroscopy Thin Layer 
Chromatography 
Fluorescence 
Spectroscopy 
X-ray Diffractometry Ion Mobility Spectrometry Melting Points 
 
Also, as a quality control, results should be compared to data generated 
by a reference material, under the same analytical conditions. However, in the 
case of drug analysis, this is not straightforward, as reference materials are 
either too expensive or not readily available.   
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2. Experimental 
2.1. Chemicals 
All solvents and reagents were obtained from commercial suppliers with 
an analytical grade and were used with no further purification. 
2.2. Equipment 
GC-MS analysis performed on a gas chromatographer (Agilent® GC 
System 6890 Series) coupled to a mass spectrometer (Agilent® 5973 Network) 
with a HP-5MS column (30m × 0.25mm × 0,25µm), using ChemStation software 
for data acquisition and processing. 
NMR spectra obtained in a Bruker Avance 400 spectrophotometer, with a 
frequency of 400,1MHz for 1H NMR and 100,6MHz for 13C NMR, using Topspin 
2.1 software for data acquisition and processing. The chemical shifts were 
expressed as  values and referenced to the residual solvent peak (DMSO-d6, 
H = 2.50, C = 39.5; CDCl3, H = 7.26, C = 77.00; methanol-d4, H =3.31, C 
= 49.00; methanol-d4, H =7.16, C =128.00) or to the signal of maleic acid 
(D2O, H = 6.42, C = 132.16); coupling constants were reported in units of 
Hertz (Hz).  The identifications of structures with respective assignments of the 
proton and carbon signals was based on the analysis of NMR spectra obtained 
by 1D (1H, 13C, APT) and 2D (including the COSY, HMBC and HSQC 
experiments) techniques. 
2.3. Samples 
Following the implementation of the new decree, all owners of any 
products sold in Portuguese smart shops (either consumers or retailers) were 
given the opportunity to voluntarily give all their products to the police, without 
facing any legal consequences in a 15-day period after the publication of new 
legislation [13]. 
Many stores from the Lisbon Metropolitan Area delivered that products to 
the police. Almost 35000 products were catalogued, according to their store (8 
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of them, named A to H), their type (plant feeders, herbal incenses and bath 
salts, for example), their brand name and their lot number. 
Figure 11 shows the quantities of each type of product catalogued. From 
this inventory, it is possible to see that the most encountered products are 
herbal incenses and plant feeders. Also, plant feeders can be divided in two 
categories: powders and pills. 
 
Figure 11 - Products from the voluntary deliveries 
Hence, due to their large presence, this work will focus on the study of 
two types of products, plant feeders and herbal incenses. 
Plant Feeders used as secondary standards for GC-MS analyses were 
acquired in Portuguese Smart shops prior to their closing. 
Herbal Incenses and Plant Feeders used for variability studies were 
provided by the LPC and were part of the volunteer deliveries followed by the 
implementation of the new Portuguese legislation. This variability studies were 
conducted in order to assess the existence of new compounds, as to obtain as 
many standards as possible. 
2.4. Sampling 
From the 17253 plant feeders, this study will focus on the powdered plant 
feeders (6374 products). For the variability studies, at least 2 samples of each 
lot number (16 lot numbers and one ‘unknown’) of each product (Blast, Bliss, 
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Bloom, Blow, Charlie, Crabby, Cyclop, Darko, Demon, E.T., Kick, Mush, Rush, 
The Cannon, Vamp) were analysed, giving a total of 103 analysed samples. 
From the 15177 herbal incenses, a first group of 33 samples was 
selected and analysed by GC-MS, consisting on one product of each brand 
name (2012, Algerian Blend, Apple, Atomic Bomb, Blow, Bombastic Kaboom 
Spliff Atomic Bomb, B.R.O.S., Buddah, Butterfly, Caramba, Cheese, Esfinge, 
Freemind, Future, Home Run, Kaboom, Magic, Mandala, MÁUI, Maya2012, 
Planet H, PUM!, Radioactive, Rainbow, Red Sunshine, Royal Mix, Smoke, So 
High, Spike99, Spliff, T-Rex, The Unicorn, Tornado, Whacked). For isolation 
and characterisation of synthetic cannabinoids, a second group of 23 samples 
was selected [Esfinge (2), Magic (2), Maya 2012 (4), Radioactive (5), Spike99 
(5), Spliff (5)] for isolation and NMR analyses of the compounds. 
2.5. Plant Feeders 
2.5.1. Standard Solutions preparation 
Methanolic solutions of the in-house standards were prepared with a 
concentration of 1mg/mL. 
2.5.2. Sample Preparation for GC-EI-MS 
Powdered samples were dissolved in methanol with a concentration of 
1mg/mL 
2.5.3. GC-EI-MS Conditions 
Samples were injected in split mode 1:50. Helium was the carrier gas. 
Initial temperature set to 80 °C, held for 1 min, then increased to 270 °C at 12 
°C/min and held for 7min. Injection Volume: 1µL. The injector temperature was 
280 °C and the GC-MS transfer line temperature was 230ºC. Electron ionization 
(EI) energy was 70eV. Scan range was 35-550 m/z. 
2.5.4. NMR Analysis 
The solutions for NMR analysis were obtained from dissolved powdered 
samples of plant feeders (approximately 10 to 20 mg) in 500 µL of D2O. 
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2.6. Herbal Incenses 
2.6.1. Sample Preparation for GC-MS Analyses: 
Each Herbal Incense was extracted in methanol to a concentration of 
100mg/mL under ultrasonication for 10/15min. The extract was filtered and 1mL 
placed on GC vials. 
2.6.2. GC-MS Conditions: 
A gas chromatographer (Agilent® GC System 6890 Series) coupled to a 
mass spectrometer (Agilent® 5973 Network) with a HP-5MS column (30m × 
0.25mm × 0,25µm) was used. Samples were injected in splitless mode. Helium 
was the carrier gas. Initial temperature set to 240 °C, held for 1 min, then 
increased to 330 °C at 6 °C/min and held for 4min. Injection Volume: 1µL. The 
injector temperature was 250 °C and the GC-MS transfer line temperature was 
230ºC. Electron ionization (EI) energy was 70eV. Scan range was 30-600 m/z 
[28, 2] 
2.6.3. NMR Analysis 
Each purified compound (10-20mg) was dissolved in 500µL of CDCl3. 
Some compounds were also analysed in benzene (d6), DMSO and MeOD. 
2.7. Isolation of Synthetic Cannabinoids from Herbal Incenses 
2.7.1. JWH-018 from “ Magic” product 
Herbal product Magic (lot 2012 43X28M; smartshop H) (3g) was 
extracted in 100mL of methanol, under ultrasonication for 10min. Extract 
evaporated to dryness. Sample restituted in 4mL of chloroform and 1mL of n-
hexane with silica 7734 and applied on a silica 9385 chromatographic column 
(18 ×4 cm) [29] packed with n-hexane. Chromatographic separation was 
performed by gradient elution using hexane (A) and ethyl acetate (B): 95A:5B 
(v/v), 30mL each for fractions 1-7; 90A:10B (v/v), 30mL each for fractions 8-33; 
85A:15B (v/v), 30mL each for fractions 34-40; 80A:20B (v/v), 30mL each for 
fractions 41-43; 50A:50B (v/v) and 0A:100B (v/v), 200mL each, for washing of 
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the column. Thin Layer Chromatography (TLC) (80A:20B) permitted the 
separation of the fractions and the collection of JWH-018 collected from 
fractions 23-29 as a yellowish oil (258.1mg). 
2.7.2. JWH-210 from “Esfinge” product 
Herbal product Esfinge (lot 2012 43X28M; smartshop H) (3g) was 
extracted in 100mL of methanol, under ultrasonication for 10min. Methanolic 
extract evaporated to dryness. Sample restituted in 2mL of chloroform with 
silica 7734 and applied on a silica 9385 chromatographic column (21 ×3 cm) 
[29] packed with n-hexane. Chromatographic separation was performed by 
gradient elution using hexane (A) and ethyl acetate (B): 95A:5B (v/v), 30mL 
each for fractions 1-7; 90A:10B (v/v), 30mL each for fractions 8-13; 85A:15B 
(v/v), 30mL each for fractions 14-25; 80A:20B (v/v), 30mL each for fractions 26-
32; 50A:50B (v/v) and 0A:100B (v/v), 200mL each, for washing of the column. 
TLC (80A:20B) permitted the separation of the fractions and the collection of 
JWH-210 collected from fractions 15-18 as a white powder (116.9mg). 
2.7.3. JWH-122 from “Magic” product 
Herbal product Magic (lot 2012 43X28M; smartshop H) (3g) was 
extracted in 100mL of methanol, under ultrasonication for 10min. Extract 
evaporated to dryness. Sample restored in 4mL of chloroform, 1mL of n-hexane 
and 1mL of methanol with silica 7734 and applied on a silica 9385 
chromatographic column (18 ×4 cm) [29] packed with n-hexane. 
Chromatographic separation was performed by gradient elution using hexane 
(A) and ethyl acetate (B): 95A:5B (v/v), 30mL each for fractions 1-7; 90A:10B 
(v/v), 30mL each for fractions 8-13; 85A:15B (v/v), 30mL each for fractions 14-
25; 80A:20B (v/v), 30mL each for fractions 26-32; 50A:50B (v/v) and 0A:100B 
(v/v), 200mL each, for washing of the column. TLC (80A:20B) permitted the 
separation of the fractions and the collection of JWH-122 collected from 
fractions 32-39, mixed with JWH-018, as a yellowish oil (188.2mg). 
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3. Results and Discussion 
In this project, plant feeders and herbal incenses were analysed by GC-
EI-MS and NMR in order to characterise the compounds present, synthetic 
cathinones and synthetic cannabinoids, to obtain secondary standards for 
routine GC-EI-MS analyses. 
3.1. Synthetic Cathinones - Mass Spectra Library 
 The goal of this study of plant feeders is to create an in-house MS library 
of synthetic cathinones as to allow for the rapid identification of these group of 
psychoactive compounds during routine analysis. The methodology applied 
consists on the identification of the compounds by NMR and MS, allowing them 
to become secondary standards for analyses by GC-MS, as it permits a correct 
identification based not only on mass fragmentation, but also on different R t for 
each compound. 
3.1.1. Initial in-house MS library of Synthetic Cathinones 
 Previous work by FCUL reported the analysis of different plant feeders 
from Portuguese stores which allowed for the identification of different 
compounds, amongst which several synthetic cathinones [17]. These 
compounds were structurally characterised using 1D and 2D NMR 
spectroscopy techniques, enabling their use as analytical standards for GC-MS 
analyses. Therefore, 8 characterised plant feeders (Blast, Bliss, Bloom, Blow, 
Charlie, Crabby, Kick, Rush) were analysed by GC-EI-MS in order to add the 
retention times and mass spectra of 8 synthetic cathinone derivatives (3,4-
DMCC, buphedrone, flephedrone, methedrone, methylone, N-ethylcathinone 
and pentedrone) (Figure 12) to build an in-house library of mass spectra of NPS 
(Table 2). However, some of the plant feeders analysed and used as secondary 
standards for GC-MS did not present only one synthetic cathinone. For 
example, Charlie product contained buphedrone and N-ethylcathinone, which, 
despite having similar Rt in GC, can be very well differentiated by NMR, as this 
technique allows the identification of the compounds, without the need to 
separate them or to have a purified sample.  
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Figure 12 - Synthetic Cathinones used to create the In-house EI-MS library 
Apart from the synthetic cathinones from plant feeders, two synthetic 
cathinones previously synthesised at FCUL were included in the library (MDPV 
[30] and MDPBP [31]). 
Table 2 - In-house EI-MS Library of Synthetic Compounds from Plant Feeders 
Compound Rt (min) Base Peak Other Relevant Fragmentations 
3,4-DMMC 10.55 58 191 [M+], 133, 105, 77 
4-MEC 9.81 72 191 [M+], 119, 105, 91, 77, 65, 44, 39 
Buphedrone 8.59 72 148, 105, 77, 57, 44 
Flephedrone 7.60 58 166, 123, 95, 75 
Methedrone 11.07 58 178, 135, 107 
Methylone 12.14 58 207 [M+], 149, 121, 42 
MDPBP 15.21 112 260 [M+], 232, 149, 121, 86, 55, 41 
MDPV 15.67 126 273, 232, 149, 86, 65, 41 
N-ethylcathinone 8.48 72 105, 77, 44 
Pentedrone 9.55 86 105, 77, 44, 51, 39 
 
As stated before, a unique characteristic of cathinones is the presence of 
a carbonyl group at the β-carbon atom, which plays an important role in the 
fragmentation of cathinones, due to the presence of the oxygen atom [32]. 
Taking the generic structure of synthetic cathinones as an example (Figure 13) 
and by looking at the base peaks in Table 2, it is possible to say that the side 
chain in the molecule of the synthetic cathinone determines its fragmentation 
pattern. 
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Figure 13 - Generic Chemical Structure of Synthetic Cathinones 
The generic primary fragmentation of synthetic cathinones follows the 
pattern seen in Figure 14. The main fragmentation in cathinones (i.e. the base 
peak) occurs in the amino group [33]. Hence, the base peaks of the alkylamine-
type cathinones are characterised by the formation of the iminium ion, which 
results from cleavaging of the α-carbon [32] (Figure 14), feature also common in 
the amphetamine class [34]. This is the reason for the low stability shown by 
amine molecular ions [35]. Thus, most EI-MS spectra of synthetic cathinones do 
not reveal the presence of the molecular ion peak. 
 
Figure 14 - Primary Fragmentation of Synthetic Cathinones 
 In Figure 15, the spectra of the cathinone analogues (3,4-DMMC, 
methedrone, flephedrone and methylone) analysed by GC-EI-MS with base 
peak m/z=58 are shown.  
   
+ 
Base Peak 
+ 
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Figure 15 - EI MS Spectra of Alkylamine Synthetic Cathinones with base peak m/z=58: 3,4-
DMMC;  Methedrone; Flephedrone and Methylone 
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All of them can be considered derivatives of methcathinone (ephedrone) 
(Figure 16), the β-keto derivative of methamphetamine, an illicit drug of abuse 
[36]. The modification observed in these compounds is observed on the phenyl 
moiety 
 
Figure 16 - Chemical Structure of Methcathinone 
 Hence, the described modification can clearly be detected by the 
fragments present in the MS if the fragments of an unsubstituted phenyl moiety 
are taken into consideration, as seen in Figure 17. Therefore, the characteristic 
fragments of the phenyl-substituted cathinones discussed next will have peaks 
that represent the differences in mass to the unsubstituted fragments. 
 
Figure 17 - Acylium and Carbenium Ions of a phenyl-unsubstituted cathinone 
 All of these compounds show a base peak of m/z 58, which is 
characteristic of the iminium ion (C3H8N+) of N-methyl substituted 
methcathinones This peak results from cleavage at the bond of the α and the β 
carbons, with the charge being retained on the fragment containing the nitrogen 
atom [37]. Also worth noting is the presence of a cluster of small fragments 
around m/z 42-44 (this clutch is present in all MS in Figure 15). This has been 
reportedly stated as characteristic of the fragmentation of aliphatic amines, 
where a clutch of peaks may be found at intervals of 14 mass units [37]. 
Methylone, or βk-MDMA, is the β-keto analogue of MDMA (3,4-
methylenedioxymethamphetamine, known as ectasy) and was patented in 1996 
as an antidepressant [38]. This was of the first cathinones to be ever reported to 
the EWS [15]. The presence of a methylenedioxy-substitution on the aromatic 
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ring is clear in this compound, with the presence of two characteristic peaks at 
m/z 149 (C8H5O3+) and m/z 121 (C7H5O2+), indicating the presence of the 
methylenedioxybenzoyl and methylenedioxyphenyl cations, respectively. The 
latter results from the loss of CO (28 Da) from the first fragment (Figure 18). 
 
Figure 18 - Secondary Fragmentation on the Acylium Ion of Methylone 
 These two fragments have also been reported for other compounds with 
this substitution. However, they have also been reported in the case of 
positional isomers, where the methylenedioxy group is in the 2,3 position [39]. 
Hence, NMR is used in order to elucidate the structure of the compound [38]. 
 Flephedrone (4-FMC or 4-fluoromethcathinone), is a methcathinone with 
a fluor substitution on the aromatic ring. This compound was first synthesised in 
1952 in order to explore its attributes as antihyroidal and antibacterial 
compound. However, according to the World Health Organisation (WHO), there 
is no medical use reported [40]. As seen in the case of methylone, its 
substitution on the aromatic ring allows the identification of fluor-substituted 
cathinones. 
 
Figure 19 - Secondary Fragmentation on the Acylium Ion of Flephedrone 
In Figure 19, the two characteristic fragments of a fluor substitution are 
shown. Firstly, the acylium ion at m/z 123 (C7H4OF+), and then the fragment 
formed after the loss of a carbon monoxide, m/z 95 (C6H4F+). These two 
fragments, correspondent to the fluorobenzyloxy and fluorophenyl cations, 
respectively, are present in MS of flephedrone, shown in Figure 15. It should be 
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noted that the position of the fluor atom cannot be determined by the analysis of 
this EI-MS fragments. Archer reported the identification of 3-
fluoromethcathinone, after identifying it uncorrectly as being flephedrone, 
merely based on GC-MS analysis [41]. However, in this case, the presence of 
flephedrone, in which the fluor atom is present in position 4, has been confirmed 
by NMR. Methedrone and 3,4-DMMC are the other two synthetic cathinones 
present in Figure 15 with the same base peak (m/z 58). Hence, following the 
premise of the fragment produced in the aromatic region by cleavage on the β 
bond to the ring in aryl alkyl ketones, 3,4-DMMC (3,4-dimethylmethcathinone) 
and methedrone have characteristic acylium fragments at m/z 133 (C9H9O+) 
and 135 (C8H7O2+), respectively (Figure 20). 
 
Figure 20 - Secondary Fragmentation on the Acylium Ions of 3,4-DMMC and Methedrone 
3,4-DMMC has not been much reported. In fact, cathinones (and even 
the amphetamine analogues) with a 3-position substitution were not much 
discussed up to 2012 [42]. This compound has a 3,4-dimethyl substitution on 
the aromatic ring, hence its fragment [105+28 (two methyl groups minus 2 
hydrogen atoms)] [43] and methedrone has a methyloxy substitution, having a 
fragment at 135 [105+30 (methyloxy group minus one hydrogen atom)] (Figure 
17). Methedrone shows a rather high toxicity, as many of the methoxylated 
synthetic cathinones [18]. It is the β-keto analogue of 
paramethoxymethamphetamine (PMMA), being responsible for two fatalities, up 
to 2010 [44]. Those acylium ions undergo further fragmentation, forming 
characteristic fragments with lower intensities m/z 105 (C8H9+) and m/z 107 
(C7H7O+), respectively for 3,4-DMMC and methedrone [18], [32] (Figure 20). 
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Figure 21 - EI MS Spectra of Alkylamine Synthetic Cathinones with base peak m/z=72 (N-
ethylcathinone; Buphedrone; 4-MEC) and with m/z=86 (Pentedrone).  
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In Figure 21, the spectra of the cathinone analogue sanalysed by GC-EI-
MS with base peak m/z 72 ((4-MEC, N-ethylcathinone, buphedrone) and m/z 86 
(pentedrone) are shown. All three cathinone derivatives with a base peak of 
72Da show similar spectrometric behaviour and hence, are structurally similar. 
This base peak has been reported as one of the most difficult one to distinguish 
between cathinones, as it is present in six commonly occurring compounds (4-
MEC, N-ethylcathinone, buphedrone, ethylone, butylone and DMMC) [32].The 
most distinguinshable one in this case is 4-MEC, due to its methyl substitution 
on the aryl moiety (hence employing the aminium fragmentation). 
 Due to being structurally very similar, the spectrometric behaviour of 
buphedrone and N-ethylcathinone is, at first glance, the same. One could 
assume that being different compounds, they would show different 
chromatographic behaviour. However, as seen in Figure 22, their retention 
times differ only by a decimal place, which is not enough for a satisfactory 
differentiation. 
 
Figure 22 - Chromatographic Separation of Secondary Standards of N-ethylcathinone and 
Buphedrone 
 The only structural difference between these two cathinone derivatives is 
the ethyl substitution. Buphedrone is an α-ethyl substituted cathinone, with 
literature references of its synthesis and initial use as a medicine for diabetes 
from 1928 [45], while N-ethylcathinone has its ethyl-substituion on the nitrogen 
atom. Based on the fact that the primary fragmentations of synthetic cathinones 
occur by cleavage of the α and β carbons, they are not sufficient to tell apart 
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this two compounds. It is therefore necessary to take a closer look at secondary 
fragmentations of these two positional isomers. 
Figure 23 - Secondary Fragmentations on the Acylium and Iminium Ions of N-ethylcathinone 
and Buphedrone 
As seen in Figure 23, the secondary fragmentations of N-ethylcathinone 
and buphedrone are not very helpful in the structural determination of these 
compounds. The acylium ion is the same [m/z 105 (C7H5O+)], thus they show 
the same carbenium ion after the loss of a CO group [m/z 77 (C6H5+)]. And 
structurally, their iminium ions are different, but their m/z values are the same 
[m/z 72 (C4H10N+)] and hence the value of the secondary fragmentation of this 
ion is also the same [m/z 44 (C2H6N+)]. However, the behaviour of the 
secondary fragmentation of the iminium ions is different. The general 
fragmentation of synthetic cathinones suggests the loss of neutral species from 
the iminium ion, leading to consequent lower mass iminium ions. This 
secondary fragmentation results largely from the loss of alkene groups, 
conceding ions of great relevance for structural elucidation [35]. In order for this 
consequent fragmentation to occur, at least an ethyl moiety substitution must be 
present. This substituent group is split from the heteroatom with hidrogen 
transfer from the leaving group to the latter [35].  
 In the study of these two compounds, only N-ethylcathinone has an ethyl-
substituion on the nitrogen atom; of course, buphedrone also has an ethyl 
substitution, but on the α-carbon. This secondary fragmentation is therefore 
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more plausible to occur in the case of N-ethylcathinone, as seen in the MS in 
Figure 21, because nitrogen has stronger charge-stabilizing properties than 
carbon [35]. 
 Although not much abundant, this phenomenon also occurs in 
buphedrone, with the loss of the methyl-substitution on the nitrogen atom, 
leading to fragment m/z 57 (C3H8N+), usually more abundant than fragment m/z 
44. This fragment is in accordance to previous reported analyses of this 
compound [46], [47] and is not present in the MS of N-ethylcathinone. 
 Nevertheless, the secondary fragmentation of the iminium ion of these 
two cathinone derivatives [intense peak at m/z 44 (C2H6N+) for N-ethylcathinone 
and peaks m/z 44 (C2H6N+) and m/z 57 (C3H8N+) for buphedrone] allows for 
their spectrometric differentiation and could be an important tool on the analysis 
of new substances that may emerge. However, these two compounds were 
added to the in-house library from the same product, a Charlie plant feeder. 
Although their differentiation by GC-MS is rather complicated, NMR allows a 
clear distinction between this two positional isomers, even if they are analysed 
as a mixture. 
 4-MEC (4-methylethcathinone) shows the same fragmentation pattern as 
N-ethylcathinone in the formation of the iminium ion and subsquent sub-
fragmentations, showing a relatively abundant peak at m/z 44, characteristic of 
the loss of the alkene group from the nitrogen atom. As expected in the case of 
cathinone derivatives, this fragmentation also leads to the formation of an 
acylium ion. In spite of that, it shows different fragments from N-ethylcathinone 
or buphedrone, yet characteristic of a methyl substitution on the aromatic ring. 
 
Figure 24 - Secondary Fragmentation of the Acylium Ion of 4-MEC 
 The peak at m/z 91 (C7H7+), the tropylium ion [32] (Figure 24), is 
generally obtained from fragmentation processes of phenylalkanes and is 
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therefore an important peak, as it is present in most spectra that contain 
phenylalkane structures [35]. 
 Further fragmentation of the tropylium ion can also be rather useful when 
aiming at understanding the presence of an alkyl-substitution on the aromatic 
ring. Aromatic-unsubstituted cathinones reveal the presence of low abundant 
ions at m/z 51 (C4H3+) and m/z 39 (C3H3+), result from the loss of an acetylene 
group and an allene diradical, respectively. Although helpful in this 
determination, as stated before, these fragments are not much abundant, as the 
benzyl core structure is rather stable [48]. Despite that, only fragment m/z 39 is 
observed in the case of 4-MEC. Instead of m/z 51, fragment m/z 65 (C5H5+) is 
observed (Figure 25). 
 
Figure 25 - Fragmentations resulting from the loss of small molecules from Aromatic Ions 
 The last compound from Figure 21 is pentedrone with a base peak of m/z 
86 (C5H12N+), an acylium ion (m/z 105), carbenium ion (m/z 77) and peaks 51 
and 39, typical of a cathinone derivative unsubstituted in the aromatic ring. Alike 
buphedrone, references of its use in the late 1920s can be found in the 
literature [45].  
 Although referred as one of the possible iminium ions in the 
fragmentation of synthetic cathinones, peak at m/z 86 is not that common. In 
this study, for example, pentedrone is the only cathinone derivative showing 86 
as its base peak. Literature is in accordance with the observed in this study. In 
his study on the fragmentation of different NSP, Zuba only describes two 
cathinones with a base peak at 86, them being pentedrone and pentylone, the 
benzyl methylenedioxy substituted analogue of pentedrone [32]. In fact, these 
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two compounds are often found on the same studies, specially when 
fragmentation patterns on EI-MS are being discussed [49]. 
 As observed for buphedrone, in pentedrone the secondary fragmentation 
does not follow the general loss of the alkyl chain in the nitrogen atom, as it only 
has an N-methyl substitution. Having said that, and as seen in Figure 26, 
fragmentation occurs on the propyl substitution on the α-carbon. This 
fragmentation is suggested by Westphal et al in their study on the 
characterisation of pentedrone [49]. Although not on the nitrogen atom, the 
process by which the iminium ion fragments is also characteristic of aliphatic 
amines and is, in principle, a second α-cleavage, confirming the loss of the 
propyl substituent [35]. 
 
Figure 26 - Secondary Fragmentation of the Iminium Ion of Pentedrone 
It has been suggested in literature that, as it has been reported for 
cathinone, synthetic cathinones may undergo processes of cyclisation and 
rearrangement to an isomeric product [21]. This reorganisation could be 
achieved via a dihydropyrazine dimer [50]. 
 In the publication on the analysis of plant feeders by our group in 
collaboration with FFUL, the presence of the iso-product of pentedrone, 
isopentedrone, was found [17]. According to that study, a content of 11% of 
isopentedrone in a mixture with pentedrone was found [17]. Hence, the 
secondary standard of pentedrone used also revealed the presence of 
isopentedrone. As seen in Figure 27, the presence of isopentedrone can also 
be verified in GC analyses. 
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Figure 27 - Chromatographic Separation of Pentedrone and its by-product, Isopentedrone 
Table 3 - GC-EI-MS Characteristics of Isopentedrone 
 
 
 
 
Figure 28 - EI-MS of Isopentedrone 
The main structural difference between pentedrone and isopentedrone is 
the location of the amino and the keto moieties, which essentially changed their 
place in the molecule. This shift in the chemical structure leads to a completely 
different MS (Figure 28), although the spectrometric behaviour is similar (Figure 
27 and Table 3) [49]. 
MS of isopentedrone showns an intense peak, the base peak, at m/z 120 
(C8H10N+). This results, as expected, from α-cleavage leading to the formation 
of a N-methylbenzyliminium ion. 
Compound Rt (min) Base Peak Other Relevant Fragmentations 
Isopentedrone 9.162 120 104, 91, 77, 42 
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Figure 29 - Primary and Secondary Fragmentations of Isopentedrone  
 Further fragmentation of the iminim ion can lead to the formation of a 
carbenium ion [m/z 77 (C6H5+)] or to the appearance of a peak at m/z 42 
(C2H4N+), which is formed by elimination of the benzene group from the iminium 
ion. However, another possible conformation for this peak at m/z 42 is a 
rearrangement and elimination process on the keto side of the chain (C2H2O+) 
(Figure 29). This proposition, given by Westphal et al in their study on the 
analysis of isocathinones by-products [49], suggests a rearrangement on the 
keto chain, followed by elimination of ethene and methylbenzylamine, resulting 
in the formation of a ketene radicalcation. This suggested rearrangement, 
succeeded by the loss of an alkene, is known as the McLafferty 
Rearrangement, which is based on the transfer of a γ-hydrogen atom with 
cleavage of the β-carbon to the carbonyl site. This can only happen if at least 
one γ-hydrogen is available that could cause the loss of an alkene group after 
β-cleavage [35]. In other words, this rearrangement could occur if one alkyl 
group with at least three carbons in length is attached to the carbonyl group of a 
ketone [51]. 
 The remaining two synthetic cathinones present in the EI-MS library are 
compounds that, on the contrary to those studied so far, belong to the 
pyrrolidine-type cathinones. They are MDPV and MDPBP, and as mentioned 
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before, these two standards were not acquired from the products of portuguese 
smart shops, but were synthesised by our group at FCUL [30, 31]. 
These two compounds are considered a derivative on another 
compound, pyrovalerone [(RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)pentan-1-
one], a synthetic compound developed as a medicine in the 1960’s, but that 
was withdrawn to the high dependence effects (Figure 30). 
 The difference between pyrovalerone and MDPV and MDPBP lies on the 
methylenedioxy substitution on the aromatic ring instead of a methyl group in 
the case of pyrovalerone (MDPBP also differs in the alkyl substitution on the α-
carbon). 
 
Figure 30 - Chemical Structure of Pyrovalerone 
 According to the EMCDDA, MDPBP was first reported in the EU in March 
2010 by the United Kingdom [15]. However, when publishing the structural 
characterisation of this compound in 2011, Westphal et al refer the seizure of a 
white powder containing this product in February 2009 [52]. 
 MDPV was first identified in Germany in 2007 [53] and its occurrence in 
Europe hit the maximum after mephedrone, another synthetic cathinone, began 
to be controlled in several countries [54]. Hence, MPDV could be considered 
the “legal” substitute od mephedrone back when it first appeared. 
However, and although all these substances are currently controlled in 
Portugal, MDPV plays an important role, as it has gone through the three-step 
process to control NPS in the EU. On January 2014, the EMCDDA and Europol 
published a Joint Report on MDPV, based on information gathered from a 
procedure initiated on October 2013 for the collection of information on this 
synthetic cathinone. Such information was mustered primarily through the 
Reitox National Focal Points. After decision of the Council, a risk assessment 
was conducted by the two european agencies and published on May 2014. This 
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risk assessment was then analysed by the Council, who, on the 25th September 
2014, published Council Implementing Decision 2014/688/EU of 25 of 
September on subjecting 25I-NBOM, AH-7921, MDPV and methoxetamine to 
control measures [55]. The merits of the basis of controlling MDPV include 108 
fatalities and 525 non-fatal intoxications in different Member States. On Article 
2, it is stated that the Member states have to place these substances in the 
appropriate legislation in order to comply with the 1971 UN Convention on 
Psychotropic Substances. In Portugal, this means that MDPV, currently 
scheduled under Decreto-Lei 54/2013 [13], shall be moved to an amendment of 
Decreto-Lei 15/93, of 22nd January, relative to the legal framework applicable to 
the trafficking and consumption of narcotics and psychotropic substances [14]. 
Although not alkylamine-type cathinones, MDPV and MDPBP are still 
structurally similar to any other synthetic cathinone and hence, their 
spectrometric behaviour is expected to be conformable to what is generally 
observable (Figure 31). 
 
 
 
 
Figure 31 – EI MS Spectra of Pyrrolidine Synthetic Cathinones with base peak m/z=112: 
MDPBP and m/z=126: MDPV 
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After α-cleavage, the formation of an acylium ion at m/z 149 occurs in 
these two compounds, suggesting the presence of an aromatic moiety, 
substituted with a methylenedioxy group, as seen for methylone in Figure 18 
and therefore not further discussed. 
 On the other hand, their iminum ions and subsequent fragmentations are 
rather characteristic. The presence of a pyrrolidine group on one of the sides of 
the carbonyl group creates interesting and rather specific fragmentations for 
these compounds. As expected, the iminium ion in pyrrolinide-type cathinones 
follows the same formation pathway as for the alkylamines types, being formed 
after α-cleavage of the carbonyl group, and creating an abundant base peak. 
 As seen in the obtained MS for these compounds (Figure 31), MDPBP 
and MDPV have base peaks of m/z 112 (C7H14N+) and m/z 126 (C8H16N+), 
respectively. The difference of 14Da between them can be explained by the 
alkyl substitution on the α-carbon, which is an ethyl group for MDPBP and a 
propyl group for MDPV. Westphal et al suggest another minor, but possible, α-
cleavage, leading to the formation of ion m/z 232 (C13H14O3N+) in both 
compounds. This is observable in the presented EI-MS for the two compounds 
and, although very low abundant, it represents the loss of the alkyl chain on the 
α-carbon, leaving a fragment characteristic of a methylenedioxy substituted 
pyrrolinide-type cathinone (Figure 32). 
 
Figure 32 - Possible α-cleavages for pyrrolidine-type cathinones, as proposed by Westphal et al 
[56] 
Following the primary fragmentations, the abundant α-cleavage 
undergoes further fragementations on the pyrrole ring. These fragments are 
present at the low mass region of the spectra, which could be complicated to 
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attribute, as they may not be very specific. Regardless, Zuba and Westphal et al 
suggest several secondary fragments characteristic of any synthetic cathinone 
with a pyrrolidine ring on the side chain: m/z 86 (C5H11N+), m/z 70 (C4H8N+) (or 
m/z 69) m/z 55 (C4H7+), m/z 42 (C3H6+)  and m/z 41 (C3H5+) [32], [57] (Figure 
33). 
Figure 33 - Secondary fragmentations on pyrrolidinophenones imminum ion 
These suggested fragments are seen in the EI-MS spectra of the 
secondary standards analysed. 
An intriguing peak usually appears on the GC chromatogram of 
pyrrolidinophenone structures, even in the case of a pure compound (Figure 
34). This peak may be present as a GC artefact, although authors have 
suggested that this could be a synthesis by-product [52]. However, its presence 
is only noticeable on GC, making it more plausible to be an artefact. 
The molecular weight of this artefact [m/z 259 (C15H17O3N+)  and the 
base peak at m/z 110 (C7H12N+), suggest a dehydrogenation on the pyrrolidine 
moiety [52]. The presence of this peak could be of interest, as its presence has 
been reported on GC analyses of other pyrrolidinophenones [52] (Figure 35). 
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Figure 34 - Chromatogram of MDPBP Standard with the presence of an artefact (highlighted in 
red) 
 
 
Figure 35 - EI-MS of MDPBP -2H, artefact present in GC analysis 
 As seen in the previous pages, synthetic cathinones follow a general 
fragmentation pattern, making it possible to group different characteristic 
fragments in order to facilitate the analysis in a forensic laboratory. The 
construction of this database allows the addiction of Rt to each compound, 
making it a valid tool in NPS identification. The identification of synthetic 
cathinones by GC-MS using these secondary standards allows the analysis of 
new samples, as it gathers information from both techniques. For each 
compound, a Rt and a MS are obtained from GC and MS, respectively. 
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3.1.2. 4F-PBP: Identification of a novel NPS 
 The EI-MS in-house library has allowed for the identification of the 
compounds present in casework samples from LPC. In January 2015, 3 white 
powder samples were analysed by GC-MS, showing one major peak in the 
chromatogram and, initially, entirely based on their MS, they were all identified 
as being MDPBP, revealing the presence of a base peak at m/z 112 and no 
molecular ion peak. However, 2 of the samples shown the same Rt, different 
from the third one, indicating that the identified substances should be different. 
A thorough analysis of the MS of the samples against the MS present iin 
the in-house library of synthetic cathinones confirmed the presence of MDPBP 
in only one of them. The other had slight differences in their MS (Figure 36). 
 
Figure 36 - Comparison of MS from Unknown Compound to MDPBP and Flephedrone 
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with different Rt did not show the presence of the m/z 149 peak (C8H5O3+), 
characteristic of the methylenedioxybenzoyl moiety, as seen in the MS of the 
MDPBP standard from the in-house library. On the contrary, they shown a peak 
at m/z 123 (C7H4OF+), which is characteristic of a fluor substitution on the 
benzene ring, as seen in flephedrone (see Figure 19) [41]. 
Taking this into account, suggestion was that the substance present in 
these two samples was a fluoro-substituted -pyrrolidinobutyrophenone (Figure 
37). 
 
Figure 37 - Chemical structure of a fluor-substituted pyrrolidinobutyrophenone 
The proposed chemical structure was elucidated and confirmed by 1D 
and 2D NMR tecnhiques at FCUL, within the scope of the undergraduate 
project of Sara Círiaco, as being 4’-fluoro-α-pyrrolidinobutyrophenone (4F-PBP) 
(Figure 38). The EI-MS analysis did not allow the attribution of the position of 
the fluor substituition on the phenyl ring. However, NMR analysis allowed the 
determination of the position of the fluor atom and revealed the presence of 
another compound, not detected by GC-MS, myo-inositol. (Figure 39). The 
structure of the coumpound was also confirmed by FTICR (C14H18FNO) at 
FCUL. 
 
Figure 38 - Chemical Structure of 4F-PBP 
The purified sample was again characterized by NMR and analysed by 
GC-MS, in order to be included in the in-house MS library ,as shown in Table 4 
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and Figure 40. As stated before, these compounds do not need to be purified to 
be included in the EI-MS library.  
 
Figure 39 - Myo-inositol found in seized white powder samples 
 
Table 4 - Addition of 4F-PBP to the in-house MS Library of Synthetic Compounds 
Compound Rt (min) Base Peak Other Relevant Fragmentations 
4F-PBP 11,25 112 233, 123, 95 
 
 
 
Figure 40 - EI-MS Spectrum of 4F-PBP 
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3.1.3. Analysis of Plant Feeders from the voluntary deliveries 
The construction of the MS library did not only allow the detection of new 
substances, as it also permited its use in order to assess the variability of the 
composition of plant feeders that were catalogued from the voluntary deliveries. 
From the 6374 powdered plant feeders from 8 different stores, there were 16 
different brand names and 17 different lot numbers. Choosing at least two 
samples for each lot number of each brand name, a total of 103 plant feeders 
were selected to analise: 73 products, with 7 different brand names (Blast, 
Bliss, Bloom, Blow, Charlie, Kick, Rush) equal to those used to create the MS 
library, and 30 space invaders with 8 diferrent brand names (Crabby, Cyclop, 
Darko, Demon, E.T., Mush, The Cannon, Vamp) ) were analysed by GC-EI-MS 
[same experimental conditions as that used with the secondary standards (see 
section 2.5.2, page 13)] . The results were compared against the created MS in 
house library, in order to assess the variability within the same lot, in products 
from different stores, but sold under the same name and lot number (Table 5,6 
and 7). The identification of the compounds present in such products was 
accomplished by comparison of the Rt with the in-house library and by 
characteristic fragmentation patterns found in MS analyses. From the 11 
synthetic cathinones present in the in-house library (3,4-DMMC, 4F-PBP, 4- 
MEC, Buphedrone, Flephedrone, Methedrone, Methylone, MDPBP, MDPV, N-
ethylcathinone and Pentedrone), 8 were identified in the 73 plant feeders 
analysed,. The compounds MDPBP, buphedrone and 4F-PBP were not 
detected and also no unknown compounds were seen in these analyses. In 
Table 5, one can see that there are qualitative variations in the composition of 
the compounds present in plant feeders between the same brand name or 
between different brands, but products do not differ qualitatively within the same 
lot number. However, in the case of mixtures, their relative abundances may 
slightly shift. This comparison of composition was based on the relative  peak 
areas of the peaks shown in the GC-MS chromatograms. This study has 
allowed for the characterisation of these type of products in Portuguese smart 
shops. An interesting thought is that consumers were being misled when buying 
products under the same name, as composition could vary within the same 
product. Similar studies have been conducted in Portugal. Products under the 
40 
 
same names were analysed, with the drawback that the number of products 
was limited in these other studies. In 2014, Zancajo et al published their results 
on the analytical profile of plant feeders from smart shops in Lisbon [18]. In the 
same year, a research was published with plant feeders bought in portuguese 
smart shops from Lisbon and Porto, prior to the closing of the stores by Araújo 
et al [17]. In most cases, the compounds detected do not vary between the 
three studies, like “Blast”, “Bloom” and “Rush” products. In the case of Zancajo 
et al, it is difficult to succeed in a comparison, as there are no lot numbers 
described and the number of samples is very limited. Nevertheless, probably 
the most peculiar cases are products “Charlie” and “Kick”. In the two published 
studies, the presence of buphedrone and N-ethylcathinone is shown. However, 
all “Charlie” samples analysed in this study show no buphedrone and instead 
pentedrone is present in all samples. “Charlie” samples analysed by Araújo et al 
were from 2012, according to their lot numbers [17]. In the case of “Kick”, 
buphedrone mixed with caffeine was reported by Araújo et al [17]. In Table 7, it 
can be seen that “Kick” products from 2013 only contained pentedrone. 
Suggestion is that buphedrone could have been replaced by pentedrone in 
“Kick” and “Charlie” products, as samples from the voluntary deliveries were 
from 2013, according to their lot numbers. This suggestion is enforced with the 
literature around these two compounds. Maheux and Copeland published the 
chemical analysis of these two compounds in 2012, referring that pentedrone 
was barely detected, while buphedrone had been found in several occasions 
[47]; also, Giné et al refer substances detected by them up to 2012 and 
pentedrone is not mentioned [59]. Also, pentedrone has been mentioned on as 
a substitute for different synthetic cathinones. In a recent study, samples under 
the same name that used to contain methylone were now analysed by the DEA 
(Drugs Enforcement Agency), revealing the presence of pentedrone [60]. Their 
structural resembleance could be a motif for the replacement. Zancajo et al do 
not report the presence of MDPV, mixed with 4-MEC, in “Blow” products. 
However, “Blow” samples with no lot number analysed by Araújo et al showed 
the same composition as the ones presented within [17], [18]. The analysis of 
these products and comparison with the existing literature could lead to a profile 
of these products in Portugal. 
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Table 5 – Relative Abundances on Plant Feeders: Comparison of lot numbers of Blast and Bliss products 
Product Lots Smartshop Compounds 
Methylone Methedrone Flephedrone Caffeine 
Blast
 
 
2012 35 12 P A   75% 25% 
F   59% 41% 
2012 46X12P A   75% 25% 
F   68% 32% 
2013 06X12P 
A   100%  
F   100%  
F   100%  
2013 13X0912P A   100%  
A   100%  
Unknown 
A   72% 28% 
F   71% 29% 
F   67% 33% 
Bliss 
 
 
2012 06X19P A  100%   
H  100%   
2012 42X16P A  100%   
F  100%   
2012 87014P G  100%   
H  100%   
2013 09X16P F  100%   
H  100%   
2013 09X19P F  100%   
H  100%   
2013 15X16P 
A 100%    
F 100%    
H 100%    
Unknown 
A 93%   7% 
C 95%   5% 
G 93%   7% 
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Table 6 – Relative Abundances on Plant Feeders: Comparison of lot numbers of Blast and Bliss products 
Product Lots Smartshop 
Compounds 
4-MEC MDPV Pentedrone N-ethylcathinone Methedrone Methylone 
Bloom
 
2013 2X19P F   54% 26% 20%  
G   51% 35% 14%  
2013 5X19P G   54% 26% 20%  
G   50% 28% 22%  
2013 09X19P 
F   47% 35% 18%  
F   47% 30% 23%  
F   48% 28% 23%  
2013 15X19P 
A   47% 27%  26% 
F   45% 26%  29% 
F   47% 32%  21% 
2013 16X19P A   42% 5%  53% 
F   42% 5%  53% 
Blow
 
Unknown 
A 83% 17%     
A 87% 13%     
C 96% 4%     
C 87% 13%     
F 90% 10%     
F 88% 12%     
F 94% 6%     
F 89% 11%     
Charle 
 
2013 14X17P 
A   51% 49%   
C   55% 45%   
F   55% 45%   
2013 15X17P 
A   52% 48%   
C   53% 47%   
F   53% 47%   
F   52% 48%   
F   53% 47%   
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Table 7 - Relative Abundances on Plant Feeders: Comparison of lot numbers of Kick and Rush products 
Product Lots Smartshop 
Compounds 
Pentedrone N-ethylcathinone Caffeine 
Kick 
 
2013 14XT5P 
A 100%   
F 100%   
F 100%   
G 100%   
Rush
 
2012 16X18P 
A 100%   
F 100%   
F 100%   
2012 42X18P 
A 93%  7% 
H 92%  8% 
H 90%  10% 
2012 35018P 
F 91%  9% 
F 90%  10% 
H 91%  9% 
H 92%  8% 
Unknown 
A 86% 7% 6% 
F 88%  12% 
F 89%  11% 
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Apart from the plant feeders already discussed, which consisted on 
products with the same brand name than those used for the construction of the 
in-house EI-MS library of synthetic cathinones, there were other products 
labelled as powdered plant feeders that were rather curious. One of the 
products initially used to build the MS library was called “Crabby” and was also 
advertised as “Space Invader”.From the voluntary deliveries, other products 
were part of what seemed a special edition under the name “Space Invader” 
(Figure 41). 
 
Figure 41 - "Space Invaders" Collection 
This collection consisted of 10 different packages, labelled from 1/10 to 
10/10. As in the case of the other plant feeders presented before, the variablity 
within “Crabby” products was assessed. However, as there were other products 
under this “collection”, it was decided to also evaluate their variability and 
possibly check for new substances that could be present in such products. 
Table 8 - Products from the "Space Invaders" collection 
Collection’s Number Product Name 
1 E.T. 
2 Vamp 
3 Crabby 
4 Demon 
6 Darko 
7 Mush 
8 The Cannon 
10 Cyclop 
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Although the names of the products change, the lot numbers on the 
packages were independent of the name. Actually, the packages seemed to be 
pre-packed and afterwards sticked with a label differentiating between them. 
Hence, the results of the analysis were dependent on lot number and the 
packaging had little to do with the variance shown. Therefore, results are shown 
for the different lot numbers, without taking into consideration the product 
names (Table 9). 
Table 9 - Relative Abundances on "Space Invaders" Plant Feeders: Comparison of lot numbers 
 
 
Lots Product Smartshop Compounds 
 3,4-DMMC Methylphenidate N-ethylcathinone 
2012 45X28P E.T. F   100% 
E.T. H   100% 
2012 46X13P 
E.T. F  100%  
E.T. F  100%  
Darko F  100%  
Darko F  100%  
Demon F  100%  
Demon F  100%  
Mush F  100%  
Mush F  100%  
Cannon F  100%  
Cannon F  100%  
E.T. F  100%  
Darko F  100%  
Mush F  100%  
E.T. F  100%  
2012 46X28P E.T. F  100%  
E.T. F  100%  
2012 47X28P 
Crabby C 100%   
E.T. C 100%   
Vamp C 100%   
E.T. F 100%   
Vamp F 100%   
E.T. F 100%   
Vamp G 100%   
Crabby H 100%   
E.T. H 100%   
2013 06X28P 
Cyclop C 100%   
Cyclop F 100%   
Cyclop G 100%   
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 30 “Space Invaders” products, consisting of at least two products of each 
lot of each package name, were analysed. Like the other products, they were 
compared against the in-house EI-MS library. From this comparison, it was 
possible to identify 3,4-DMMC and N-ethylcathinone in some of the samples. 
However, in most of the samples (16 samples), there was no positive match 
with any of the compound from the library. Hence, the MS of these products 
were compared against the SWGDRUGS library, using the PBM search 
method. In this search method, reference spectra and unknown spectrum are 
usually compared by forward search, meaning that the fragments of the 
unknown spectrum must be present in the reference spectra [34]. It is therefore 
essential to eliminate any background signals that may exist. The difference on 
a MS after subtraction of the background can make a great difference in 
identification. 
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As seen in Figure 42, the subtraction of the background allowed the 
correct assignment of the base peak and changes in relative abundances of 
other peaks. One of the biggest disadvantages of the PBM search method is 
the fact that it is very much dependent on the data acquisition parameters of the 
instrument and the choice of the region of the peak. This leads to different 
spectra per substance in this search method [34]. Regardless, this method has 
allowed for the identification of a substance that showed the same Rt in all the 
samples (around 12.5min). In Figure 43, the first two compounds with higher 
matches with the library used are shown. Based on the quality percentages 
assigned by the search, the compound could be identified as methylphenidate. 
 
 
Figure 43 - PBM Search Result of sample CL93-4: Comparison with Methylphenidate and 
Ethylphenidate standards from SWGDRUGS library 
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 Although there is a differentiation on the quality percentage attributed to 
methylphenidate and ethylphenidate, they are very similar and a differentiation 
based on MS puts up a great challenge. A similar spectrometric behaviour 
would be expected for these compounds, as their only structural difference is 
the substitution on one of the sides of the carbonyl group (methyl substitution 
for methylphenidate and ethyl substitution for ethylphenidate) (Figure 44). 
Methylphenidate is considered a stimulant medication, usually prescribed 
to both children and adult that suffer from attention-deficit hyperactivity disorder 
(ADHD) [61]. In Portugal, methylphenidate is a controlled substance under Dec-
Lei 15/93, of 22nd of January, which criminalises the trafficking of the 
substances present in the table appended on the decree. However, according 
to its article 15, it is possible to supply methylphenidate to the general public by 
medical prescription [14]. However, to the best of our knowledge, there are no 
records of the use of methylphenidate in plant feeders. In fact, based on the 
principle that NPS are used to circumvent existing legislation, it would not make 
much sense to detect this compound in this type of products. 
 
Figure 44 - Chemical Structures of Methylphenidate and Ethylphenidate 
 Ethylphenidate is usually found as a metabolite, after the combined 
ingestion of methylphenidate and ethanol, as a product of transesterification 
(Figure 45) [62]. 
 
Figure 45 - Synthetic Route for Ethylphenidate (Casale and Hays, page 58) [63] 
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However, ethylphenidate has been found in different products sold as 
‘legal highs’. Casale and Hays refer the legality of the substance, although 
stating that, in the US, it could be considered an analogue of methylphenidate, 
a controlled substance. In Portugal, methylphenidate is placed on an annexed 
table of Decreto.Lei 15/93 [14] that includes derivatives or analogues. Hence, 
ethylphenidate can be scheduled in the same legislation; despite that, this 
compound was put under control in Portaria 154/2013, under Decreto-Lei 
54/2013 [13]. As their EI-MS differentiation is complicated, the compound was 
analysed by NMR in order to obtain a structural elucidation of the compound. 
 A sample of E.T. Space Invader was analysed by NMR in D2O. Analysis 
of the 1H NMR and HSQC spectra of the unknown compound in D2O revealed 
the presence of 20 protons: one methyl signal at δ1.14 (3H, t, J=7.2Hz); two 
methine signals at δ3.79 (1H, td, J=10.0/2.4Hz) and δ3.95 (1H, d, J=9.2Hz); five 
methylene signal at δ1.37/δ1.59 (2H, m/m), δ1.40/1.79 (2H, m/m), δ1.59/δ.1.84 
(2H, m/d, J=14.4Hz), δ3.04/δ3.42 (2H, td/brd, J= 2.8/12.8Hz / J=12.8Hz) and  
δ4.18 (2H, m) and five aromatic protons at δ7.29 (2H, d, J=6.8Hz) and δ7.42 
(3H, m). 13C APT NMR spectrum revealed the presence of 15 carbons, 
suggesting a carbonyl carbon at δ172.71; one aromatic quaternary carbon at 
δ133.29; five aromatic methine carbons at δ128.58 (2 carbons), δ128.79 and 
δ129.42 (2 carbons); two methine carbons at δ53.79 and δ57.83; five 
methylene carbons at δ21.24, δ21.73, δ26.16, δ45.54 and δ62.97; and one 
methyl carbon at δ12.98. 
  1D and 2D correlation techniques allowed for the correct assignment of 
the signal, as seen in Figure 46 and Table 10. 
 
 
 
 
Figure 46 - Key COSY and HMBC correlations in Ethylphenidate 
 Attribution of the signals for ethylphenidate started with the quaternary 
carbon at δC172.71 (position 1), characteristic of a carbonyl carbon. The 
 COSY 
 
 HMBC 
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methine group at C2 (δH3.95, d, J=9.2Hz; δC57.83) showed an HMBC 
correlation with the aromatic methine protons at C2’’’ and C6’’’ (δH7.29, d, 
J=6.8Hz; δC128.58), also allowing the attribution of C1’’ (δH3.79, td, 
J=10.0/2.4Hz; δC53.79). The other aromatic positions were attributed as C3’’’ 
and C5’’’ (δH7.42, m, overlapped; δC129.42). The other N-methylene group at 
C5’’ (δH3.04/δH3.42, td/brd, J= 2.8/12.8Hz/J=12.8Hz) showed a COSY 
correlation with the methylene group at C4’’ (δH1.59/δH1.84, m/d, J=14.4Hz; 
δC21.73), allowing their attribution. Positions 2’’ and 3’’ were differentiated by an 
HMBC correlation between the methine group at C2 and the methylene protons 
at C2’’. The methyl group (δH1.14, t, J=7.2Hz; δC12.98) and the methylene 
group (δH4.18, m; δC62.97) were assigned as C2’ and C1’, respectively. 
Table 10 - 1H and 13C NMR signals of Ethylphenidate 
Position 13C NMR 1H NMR 
1 172.71 - 
2 53.79 3.95, d, J=9.2Hz 
1’ 62.97 4.18, m 
2’ 12.98 1.14, t, J=7.2Hz 
1’’ 57.83 3.79, td, J=10.0/2.4Hz 
2’’ 26.16 1.59m, 1.37m 
3’’ 21.24 1.79m; 1.40m 
4’’ 21,73 1.84d, J=14.4Hz; 1.59m 
5’’ 45.54 3.42 brd, J=12.8Hz; 3,04td, J= 2.8/12.8Hz 
1’’’ 133.29 - 
2’’’/6’’’ 128.58 7.29, d, J=6.8Hz 
3’’’/5’’’ 129.42 7.42, m, overlapped 
4’’’ 128.79 7.42, m, overlapped 
 
The compound was elucidated as being ethylphenidate and was 
analysed by GC-EI-MS in order to include it in the in-house EI-MS library. 
 
Table 11 - Addition of Ethylphenidate to the EI-MS Library of Synthetic Compounds 
Compound Rt (min) Base Peak Other Relevant Fragmentations 
Ethylphenidate 12.56 84 146, 91, 77 
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Figure 47 - EI-MS of Ethylphenidate 
The EI fragmentation of ethylphenidate gives a base peak of m/z 84 
(C5H10N+), resulting from the formation of a piperidinium ion. Also a “second” 
base peak could be the tropylium ion at m/z 91 (C7H7+), formed by cleavage 
with the carbonyl group, after loss of the piperidinium ion. As discussed before, 
the tropylium ion can undergo further fragmentation, forming the carbenium ion 
at m/z 77 (C6H5+), present in the spectrum. The piperidinium ion can also suffer 
a secondary fragmentation, resultant from a transannular cleavage. This 
fragmentation is characteristic of saturated heterocyclic compounds, and, 
fundamentally, consists on a cut across the ring structure [35]. In the case of a 
piperidine structure, it consists on the loss of an imine (m/z 29), resulting in a 
peak with m/z 56. However, these fragmentations are common to both 
methylphenidate and ethylphenidate. Nevertheless, there is a minor 
fragmentation that could be used to distinguish between these two compounds. 
In Figure 47, a peak at m/z 146 (C10H12O+) is pointed out. This peak is 
considered the complementary peak after the formation of the piperidinium ion, 
hence standing out the ethyl phenylacetate moiety. In a spectrum of 
methylphenidate, a peak at m/z 150 should be expected (Figure 47) [63]. 
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3.1.4. Analysis of seized samples of plant feeders 
Following the analyses of plant feeders from the voluntary deliveries and 
the assumption that products under the same name could have different 
compositions over time, results from samples seized from smart shops in 2011 
(prior to the new legislation and the closure of the stores) with the same brand 
name as those previously discussed, were looked at. This was done in order to 
verify the existence of any other substances that could be present in the market 
before closure of the smart shops and, hence, add more compounds to the EI-
MS library.  
 From this search, a result from a “Blow” product gave a positive match 
with existing libraries for mephedrone. This result is of particular interest, as 
mephedrone is one of the most known synthetic cathinones and was the first 
cathinone derivative to undergo the three-step approach by the EMCDDA and 
Europol [53], leading to Council Decision 2010/759/EU of 2 December 2010 on 
submitting 4-methylmethcathinone (mephedrone) to control measures, by which 
all Member States should submit this compound to control and criminal 
penalties [64]. In Portugal, mephedrone was added to Decreto Lei 15/93 in its 
nineteenth amendment, with Law no 13/2012, of 26 of March. Recently, a 
decision was made in the UN Commission on Narcotic Drugs to place 
mephedrone in Schedule I of the 1971 Convention. 
 The structural characterisation of this compound was confirmed by NMR, 
using D2O as the solvent. Analysis of the 1H NMR spectrum of mephedrone in 
D2O revealed the presence of 14 protons: three methyl signals at δ1.62 (3H, d, 
J=7.2Hz), δ2.45 (3H, s) and δ2.82 (3H, s); a methine signal at δ5.09 (1H, d, 
J=7.2Hz) and four aromatic protons at δ7.45 (2H, d, J=8.0Hz) and δ7.93 (2H, d, 
J=8.4Hz). 13C APT NMR spectrum revealed the presence of 11 carbons, 
suggesting a carbonyl carbon at δ197.95, two aromatic quaternary carbons at 
δ130.50 and δ148.24; four aromatic carbons at δ129.90 (2 carbons) and 
δ130.74 (2 carbons); a methine carbon at δ60.37 and three methyl carbons at 
δ16.27, δ21.83 and δ31.76. 
1D techniques and 2D correlation techniques allowed for the attribution 
of the signals, as seen in Figure 48 and Table 12. 
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Figure 48 - Structure of Mephedrone and key COSY and HMBC correlations 
Attribution of the signals for mephedrone started with the quaternary 
carbon at δC197.95 (position 1), characteristic of a carbonyl carbon. C1 showed 
HMBC correlations with protons at positions 2 (δH5.09, d, J=7.20Hz δC60.37;), 3 
(δH1.62, d, J=7.20Hz; δC16.27) and 6’/2’ (δH7.93, d, J=8.40Hz; δC130.74;), 
allowing their correct assignment. Also, H2 showed a COSY correlation with the 
mehyl at δ1.62 atributed to C3. The other aromatic signals (δC129.90; δH7.45, d, 
J=8.00Hz) were attributed to positions 3’ and 5’ by the COSY correlation 
beteween δH7.93 (H6’/H2’) and δH7.45. 
Table 12 - 1H (400.13MHz) and 13C (100.6MHz) spectral data of Mephedrone recorded in D2O 
Position 13C NMR 1H NMR 
1 197.95 - 
2 60.37 δ5.09 (1H, d, J=7.2Hz) 
3 16.27 δ1.62 (3H, d, J=7.2Hz) 
4 31.76 δ2.82 (3H, s) 
1’ 130.5 - 
2’/6’ 130.74 δ7.93 (2H, d, J=8.4Hz) 
3’/5’ 129.90 δ7.45 (2H, d, J=8.0Hz) 
4’ 148.24 - 
7’ 21.83 δ2.45 (3H, s) 
 
 HMBC correlation between a quaternary carbon (δC148.24) and a methyl 
group (δH2.45, s; δC21.83) permitted the attribution of 4’ and 7’, respectively. 
With an aromatic carbon and a methyl group left, attribution of 1’ and 4 as 
δC130.50 and (δC31.76; δH2.82, s) was possible.  
After structural elucidation by NMR, the product was analysed by GC-
MS, using the same methodology used for the other plant feeders. Because the 
compound could be identified by NMR as being mephedrone, this analysis was 
 
 
 COSY 
 
 HMBC 
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conducted in order to add a Rt and a MS for this compound to the in-house 
library (Figure 49 and Figure 50). 
 
 
 
 
 
 
Figure 49 – Retention Time of Mephedrone 
 
Figure 50 - EI-MS of Mephedrone 
 The spectrometric behaviour is the expected for a methyl substituted 
methcathinone, as seen in other cases discusses above. Characteristic iminium 
and acylium ions reflect the substitution patterns, as well as secondary 
fragments, which were already presented and discussed in Figure 24. 
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The analysis of 115 samples of plant feeders (8 initial standards, 103 
products from voluntary deliveries and 4 seized sample) has allowed the 
construction of an in-house EI-MS library of 12 synthetic cathinones (3,4-
DMMC, 4-MEC, 4F-PBP, Buphedrone, Flephedrone, MDPBP, MDPV, 
Mephedrone, Methedrone, Methylone, N-ethylcathinone and Pentedrone) plus 
ethylphenidate (Figure 51). This is of the uttermost importance for a routine 
laboratory, as the thorough study of the spectrometric and fragmentation 
behaviour of these compounds may aid in the discovery of novel NPS and in 
the continuous monitoring of already existing substances. Common 
fragmentations make them easier molecules to assess and the advantage of an 
Rt facilitates the correct identification on these compounds. Indeed, the 
methodology used and the in-house library allowed the identification of a new 
synthetic cathinone in Europe, 4F-PBP, firstly suggested by MS comparison 
with the secondary standards and then confirmed by NMR analyses. The 
variability studies permitted the study of the qualitative and quantitative 
variations of synthetic cathinone in Portugal. An interesting remark is that, of the 
more of 70 synthetic cathinones already reported in the EU [65], only 12 could 
be found in Portuguese smart shop from 2011 to 2013, plus ethylphenidate and 
caffeine. 
 
Figure 51 - Final In-house EI-MS Library with Compounds from Plant Feeders 
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3.2. Mass Spectrometry Library of Synthetic Cannabinoids 
3.2.1. Preliminary GC-EI-MS analysis 
In order to build an in-house library that contained more than synthetic 
cathinones, herbal incenses, known to contain synthetic cannabinoids, were 
analysed. Of the 15177 herbal incenses products, there were only 33 different 
brand names (2012, Algerian Blend, Apple, Atomic Bomb, Blow, Bombastic 
Kaboom Spliff Atomic Bomb, B.R.O.S., Buddah, Butterfly, Caramba, Cheese, 
Esfinge, Freemind, Future, Home Run, Kaboom, Magic, Mandala, MÁUI, 
Maya2012, Planet H, PUM!, Radioactive, Rainbow, Red Sunshine, Royal Mix, 
Smoke, So High, Spike99, Spliff, T-Rex, The Unicorn, Tornado, Whacked). One 
package of each brand name was analysed by GC-MS, in order to do a 
preliminary identification of the compounds present in the products. 
 As seen in the Introduction section (section 1.4.), these products are 
known to contain synthetic cannabinoid receptor agonists. Hence the GC-MS 
method chosen, a recommended method by the UNODC, which is destined to 
forensic expert laboratories, in order to qualitatively analyse such substances 
[28]. In Table 14, the identification of the compounds present in 23 of the 33 
products is shown [in 10 products (Algerian Blend, Apple, Bombastic Kaboom 
Spliff Atomic Bomb, B.R.O.S., Cheese, Home Run, Planet H, PUM!, Red 
Sunshine, Smoke and Tornado) no compound was detected]. The identification 
of these compounds was based in a PBM search against known EI MS spectra 
libraries, like the SWGDRUG or ENFSI DRUGS 2015 [34]. This initial analysis 
revealed the presence of 10 different synthetic cannabinoids, as well as other 
compounds, such as MDPV (a synthetic cathinone already found in herbal 
incenses [66]), vitamin E (a natural metabolite usually found in the plant used as 
matrix in herbal incense products [10]) and caffeine (a common adulterant of 
NPS) and 5-MeO-DALT (Figure 52), which is a psychoactive substance, 
derivative of the natural occurring monoamine alkaloid, tryptamine. This 
substance was first synthesised by Alexander Shulgin [67]. Up to 2012, there 
had been some reports of the use of this substance in herbal mixtures, although 
it was more commonly found in capsules or as a white powder [68]. 
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Figure 52 - Chemical Structure of 5-MeO-DALT 
Herbal Incense products where caffeine was present were curious. Blow, 
Future and Butterfly were advertised as herbal incenses. However, the contents 
of the packages were white powders. In any case, samples were prepared 
following the same methodology applied to herbal incenses, in order to 
investigate the presence of any synthetic cannabinoid in these products. Initial 
analysis by GC-EI-MS revealed the presence of caffeine. The obtained MS is 
shown as an example of the results. 
 
Figure 53 - EI-MS of Caffeine 
The primary analysis of the synthetic cannabinoids detected is shown in 
Table 13. 
Table 13 - GC-EI-MS Results of Preliminary Analysis 
Compound Number of 
Detections 
Rt (min)] Base 
Peak 
Other EI Fragmentations Library; PBM 
Search Match % 
JWH-210 9 [16.4-16.6] 369 [M+] 312, 298, 214, 183, 144 SWGDRUG; [86-99] 
JWH-018 6 [14.4-14.5] 341 [M+] 284, 270, 214, 155, 144, 127 SWGDRUG; [93-99] 
JWH-122 12 [15.8-16.0] 355 [M+] 298, 284, 214, 169, 144, 141 SWGDRUG; [89-99] 
JWH-250 6 [11.4-11.7] 214 335 [M+], 214,144, 121, 91 SWGDRUG [83-99] 
MAM2201 1 17.2 373 [M+] 298, 284, 232, 144, 141, 115 SWGDRUG, 99 
AKB-48 2 [13.7-13.9] 215 365 [M+], 308, 294, 187, 135 SWGDRUG, [97-99] 
AM-694 2 13.6 232 435[M+], 360, 220, 204, 144 SWGDRUG, 97 
Cl-AM-694 2 16.0 248 451 [M+], 360, 220, 204, 144 SWGDRUG, 95 
AM-1248 2 17.9 98 390 [M+], 292, 135, 98, 70 SWGDRUG, 83% 
UR-144 1 7.0 214 311 [M+], 144 SWGDRUG, 99 
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Table 14 - Preliminary GC-MS Identification of Compounds present in 23 Herbal Incenses 
* Or one of the positional isomers of JWH-250: JWH-302 or JWH-201 
1 Vitamin E 
2 MDPV 
3 5-MeO-DALT 
Product 
Compound 
JWH-210 JWH-018 JWH-122 MAM2201 JWH-250 AKB48 UR-144 
AM-694 chloro 
derivative 
AM-694 AM-1248 Caffeine Other 
Esfinge X 
           
MÁUI X X X X 
       
1 
Caramba X 
 
X 
        
1 
Mandala 
 
X X 
         
Buddah X X X 
        
1 
2012 X X X 
        
1 
Atomic Bomb 
           
2 
Kaboom 
    
X* 
       
Blow           X  
So High 
  
X 
 
X* 
       
Future           X  
Rainbow X 
   
X 
       
Butterfly           X  
T-Rex 
           
2 
Spliff 
  
X 
 
X 
       
The Unicorn X 
 
X 
 
X 
     
  
Whacked 
     
X 
    
  
Royal Mix X 
 
X 
 
X 
     
  
Maya2012 
     
X X 
     
Magic 
 
X 
          
Freemind X X X 
         
Radioactive 
  
X 
    
X X X 
 
3 
Spike99 
  
X 
    
X X X 
 
3 
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 The initial identification of the synthetic cannabinoids present in the 23 
samples of herbal incenses was achieved by comparing the obtained MS to the 
reference MS of the SWGDRUGS library, using the PBM method described 
before, the literature and by analysing their fragmentation pattern. On the next 
page, the obtained MS of 3 synthetic cannabinoids of the naphtoylindole family 
are shown. According to the match with the library, they could be identified as 
being JWH-018, JWH-122 and JWH-210, respectively. As they belong to the 
same compound family, it should be expected that their structures and, hence, 
their spectrometric behaviour, were similar. In fact, they not only belong to the 
same family, as they only differ on the substitution on the same position on 
naphthoyl side of the structure. As seen in Figure 54, JWH-018 is unsubstituted, 
JWH-122 has a methyl substitution and JWH-210 has an ethyl substitution in 
the para-position. The rest of the structure is the same in the 3 compounds. 
 
Figure 54 - Chemical Structure of JWH-018, JWH-122 and JWH-210 
Unlike the case of synthetic cathinones, these structures do not undergo 
extensive fragmentation under EI conditions. As a matter of fact, their molecular 
ion is not only present in the MS, as it is, in most of the cases, the base peak 
[69], [70], [71]. Figure 55 shows the EI-MS spectra of the 3 compounds 
obtained in the GC-EI-MS analysis of herbal incenses. The main primary 
fragmentations of these compounds occur in the indole moiety, either with the 
loss of the pentyl-substitution on the nitrogen atom (Fragments B, Figure 56), 
the loss of the naphthalene group, with transfer of charge to the oxygen atom of 
the carbonyl (Fragments D, Figure 56) or with the loss of the carbonyl group, 
leading to a fragment with a loss of 17 Da [M-17]+ [72] (Fragment A, Figure 56).  
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Figure 55 - EI-MS of 3 Naphthoylindoles Synthetic Cannabinoids: JWH-018, JWH-122, JWH-
210 
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JWH-018; R=H [73] 
M.W. = 341 
JWH-122; R=CH3 [74] 
M.W. = 355 
JWH-210; R=C2H5 [75] 
M.W. = 369 
A 324 338 352 
B 284 298 312 
C 270 284 298 
D 214 214 214 
E 144 144 144 
F 155 169 183 
G 127 141 155 
Figure 56 - Major fragment ions in the EI-MS of 3 Naphthoylindoles: JWH-018, JWH-122 and 
JWH-210 
 Minor and secondary fragmentations occur on both sides of the 
molecule. Fragments F and G show characteristic naphthoyl and naphthalene 
fragments, respectively [76]. An interesting fragment is the secondary 
fragmentation E, showing the indole moiety with the charge on the oxygen of 
the carbonyl, without the pentyl substitution. This fragment, mainly consisting on 
the indole structure, could be considered a specific fragment. Loss of the 
carbonyl group is possible, as seen on fragment A. Therefore, it is suggested 
that fragment E could suffer a tertiary fragmentation, losing the carbonyl group 
and leading to a fragment with an m/z 116 (C8H6N+), resulting from the loss of 
28Da (C=12Da + O=16Da). Analysing the MS present in Figure 55, the 
presence of a small fragment with the m/z of 116 is noticeable. This is 
consistent with the literature, where several reports on the EI-MS behaviour of 
these compounds revealed the presence of a small fragment with an m/z 116 
B 
C 
E 
G 
D 
F 
A 
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[70], [74], [75]. On the case of JWH-122, this smaller fragment is difficult to 
observe when looking at the full spectrum, due to the presence of a peak with 
higher intensity at m/z 115 [77]. As seen in the case of cathinones with a benzyl 
group, where the loss of an acetylene group leads to a cyclopentadienyl ion, it 
could be suggested that the same fragmentation occurs in compounds with a 
naphthyl group, as it is the case of JWH-122. Thus, the loss of an acetylene 
group (26Da) from the naphthyl fragment [m/z 141(C11H9+)] could lead to a 
fragment of m/z 115 (C9H7+) [48]. The same fragments were reckoned on the 
analysis of the other identified synthetic cannabinoids, in order to assess the 
presence of other indole-type compounds or substances with a 
naphthoyl/naphthalene moiety. 
 An interesting compound is MAM2201, that could be considered the fluor 
derivative of JWH-122, (Figure 57) [78]. To the best of our knowledge, MAM-
2201 was first reported to be isolated from a commercial product in 2012, 
coupled with its naphthalene unsubstituted analogue, AM-2201 [79]. 
 
 
Figure 57 - EI-MS of MAM2201 
As seen for the previous compounds, the base peak for MAM-2201 is its 
molecular ion [m/z 373 (C25H24FNO+). This could be an indication of a fluor 
substitution on JWH-122, due to the difference of 18Da in the molecular ions 
[JWH-122 [M+]: m/z 355 (C25H25NO+)]. This difference should be present in all 
fragments were the pentyl substitution is present. Based on this premise, the 
spectra of MAM-2201 and JWH-122 were compared in order to assess the 
existence of such fragments (the same nomenclature for the fragments as seen 
in Figure 56). 
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Fragment JWH-122 
R=CH3; M.W. =355 
MAM-2201 
R=CH2F; M.W. = 373 
A 338 356 
B 298 298 
C 284 284 
D 214 232 
E 144 144 
F 169 169 
G 141 141 
Figure 58 - Comparison of Fragments of JWH-122 and MAM-2201 
As seen in Figure 58, fragments A and D (where the substitution on the 
indole moiety is present) reveal fragments with an increase of 18Da for MAM-
2201. Also, the presence of the naphthyl group can be confirmed by the 
presence of fragments F and G. Nevertheless, the presence of a methyl 
substitution on MAM-2201 can also be confirmed by the occurrence of a peak at 
m/z 115 (C9H12+). 
The two compounds with a pentyl-substitution on the indole moiety, but 
with different substituent groups on the other side of the carbonyl are JWH-250 
and UR-144 (Figure 59). To our knowledge, analytical information on JWH-250 
was first reported in 2011, by Nakajima et al [80], and on UR-144 by Choi et al, 
in 2013 [81].  
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Unlike the naphthoylindoles analysed before, the base peaks of JWH-
250 and UR-144 are not their molecular ion. In these compounds, the 
characteristic fragment of a pentyl-substituted indole with the charge on the 
oxygen atom of the carbonyl group at m/z 214 (C14H16NO+) is the base peak, 
with the molecular ion being almost absent of the full EI spectrum (Figure 59). 
Taking into consideration the fragmentation patters occurring in synthetic 
cathinones, where α-cleavage accounts for the main fragmentation, and 
considering that fragment m/z 214 could be assumed as an acylium ion, 
chances are that, in JWH-250 and UR-144, α-cleavage occurs as the main 
fragmentation pathway. 
 
 
 
Figure 59 - EI-MS of Pentyl-substituted Indoles Synthetic Cannabinoids, JWH-250 and UR-144 
 The occurrence of this peak in JWH-250 was shown by Gwak et al [82]. 
They performed different MRM (Multiple Reaction Monitoring) analyses on this 
compound (and on JWH-018, JWH-122 and JWH-210) that revealed that the 
primary fragmentation that occurs on the JWH-250 is the formation of the peak 
at m/z 214 (C14H16NO+). Looking at the structure of the compound, an α-carbon 
is present on one of the sides of the carbonyl group. Alike, in UR-144 there is 
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also an α-carbon. Therefore, as seen in the case of cathinone derivatives, JWH-
250 and UR-144 suffer α-cleavage, leading to the formation of acylium ions. 
This can also be confirmed by the presence of a peak at m/z 144 (C9H6NO+) in 
both compounds. This is formed by loss of the carbonyl group in the acylium 
ion, as seen in Figure 56. Although present in these compounds as their base 
peak, m/z 214 can be found in all synthetic cannabinoids with a pentyl-
substituted indole moiety, as seen in Figure 60. 
 
Figure 60 - Formation of peak at m/z 214 in all pentyl-substituted indole synthetic cannabinoids 
 JWH-250 has a characteristic moiety on the other side of the carbonyl 
group. Coupled to the α-carbon is an anisole group. This group is characterised 
by a benzene ring substituted with a methoxy group (hence, its common name 
methoxybenzene). Following α-cleavage, and apart from the base peak, 
another possible ion is the methoxybenzenium ion. This ion is shown in a peak 
at m/z 121 (C8H9O+) (Figure 61). Although literature suggests that aromatic 
rings often considerably stable, this peak is barely present in the MS for this 
compound. However, the study by Gwak et al refers the presence of this peak. 
Nonetheless, the presence of an aromatic ring in this compound can be 
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confirmed by the peak at m/z 91 (C7H7+) that, as seen before, results from 
benzylic cleavage of a substituted benzenium ion [34]. 
 
Figure 61 - EI-MS Fragmentations on the Anisole Moiety of JWH-250 
Like JWH-250, UR-144 also shows an interesting moiety on the other 
side of the carbonyl group, a tetramethyl substituted cyclopropane ring. 
Cyclopropane rings are known to be thermally unstable and this poses a 
challenge on the EI-MS analysis of compounds with this group present. In fact, 
when analysing the MS shown in Figure 59, few peaks are abundant and 
indicative of the fragments that characterise this compound. The three major 
peaks are m/z 214 (C14H16NO+), m/z 144 (C9H6NO+) and m/z 311 (C21H29NO+), 
the latter being the molecular ion and the first two related to the pentyl-
substituted indole moiety, as described before. Hence, there are no major 
fragmentations characteristic of the cyclopropane ring. This is in accordance 
with the literature. Different reports on the GC-EI-MS analysis of UR-144 do not 
show any relevant peaks that could indicate the moiety on the other side of the 
carbonyl group [83], [84], [81]. However, taking m/z 311 and m/z 214 into 
consideration, suggestion is that the fragment characteristic of the other side of 
the carbonyl group will show a peak at m/z 97, resulting from the loss of 214Da 
from the molecular ion of 311Da. Nevertheless, there is no peak at m/z 97 on 
the MS in Figure 59. Despite that, and assuming that a tetramethyl substituted 
cyclopropane ring is present, a peak of this mass would be possible [m/z 97 
(C7H14+)]. 
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 Nonetheless, the fact that the cyclopropane moiety is thermally unstable 
yields a characteristic GC behaviour, with the appearance of a second peak, 
usually just immediately next to the compound of interest and that reveals a 
rearrangement in the cyclopropane group [83]. This peak will then be analysed 
by the MS as if it was an unknown compound [35]. Literature suggests that this 
rearrangement product is based on the opening of the cyclopropane ring [83], 
explained by the presence of an abundant fragment 15Da greater than the base 
peak of UR-144 and with the same molecular ion, as seen in Figure 61. 
Kennedy et al suggested that this degrading product could suffer a McLafferty 
rearrangement, which is possible, considering the presence of a y-hydrogen 
and a β-carbon [85]. The EI-MS of the UR-144 cyclopropyl rearrangement 
product is shown below (Figure 62). 
 
 
Figure 62 - EI-MS of UR-144 cyclopropyl rearrangement product 
 This MS shows the same molecular ion as UR-144 [m/z 311 
(C21H29NO+)] and the characteristic peaks of a pentyl-substituted indole moiety, 
m/z 214 (C14H16NO+) and m/z 144 (C9H6NO+) (Figure 62). The other relevant 
peak is the radical cation at m/z 229 (C15H19NO+) that results from proton 
migration. This peak confirms the acyclic structure of the product, after 
rearrangement of the cyclopropyl moiety of UR-144 (Figure 63) [86]. 
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Figure 63 - Principal Fragmentations of UR-144 and its cyclopropyl rearrangement product 
 AM-694 and its chloro derivative were also identified in the initial analysis 
of herbal incenses.AM-694 was first reported in the literature as an adulterant in 
herbal blends by Nakajima et al in 2011 [70], but was reported to the EMCDDA 
via the EWS in 2010 by the Irish authorities. Its chloro derivative was first 
reported in 2011 by German authorities and, to the best of our knowledge, there 
are no reports discussing this compound in the literature [26]. The analysis of 
other synthetic cannabinoids lead to the assumption that in certain cases, the 
base peak is the molecular ion. Despite that, compounds in which α-cleavage is 
possible to occur present a base peak different than the molecular ion and 
resulting from the referred cleavage. In the case of these two compounds, one 
could think that they undergo α-cleavage, due to their base peaks not being the 
molecular ions. However, there is no prominent base peak, so this type of 
cleavage is most likely not occurring in these compounds, as it would lead to a 
very bulging peak. As seen in Figure 64, the presence of peaks m/z 144 
(C9H6NO+) and m/z 116 (C8H6N+) indicate the presence of an indole moiety, as 
seen for the compounds discussed before [87]. 
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 However, there is no prominent base peak, so this type of cleavage is 
most likely not occurring in these compounds, as it would lead to a very bulging 
peak. As seen in Figure 64, the presence of peaks m/z 144 (C9H6NO+) and m/z 
116 (C8H6N+) indicate the presence of an indole moiety, as seen for the 
compounds discussed before [87]. However, the absence of a peak at m/z 214 
(C14H16NO+) suggests other substitution on the indole group than a pentyl 
chain. Taking this into consideration, the base peak at m/z 232 has more 18Da 
than m/z 214. In the case of MAM2201 and JWH-122, this difference was seen 
and the presence of a fluor atom was observed. Hence, the base peak with m/z 
232 could express the presence of a fluor atom and could result from the loss of 
the iodobenzyl moiety from the molecular ion. Also, the difference between 
molecular ion and base peak (203Da), suggests the presence of a iodo-
substituted benzene ring (C6H4I = 203Da) (Figure 65) [88]. 
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Figure 64 - EI-MS of two Benzoylindoles, AM-694 and AM-694 chloro derivative 
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Figure 65 - Fragmentation of AM-694, forming the base at m/z 232 
 The same premise can be applied to the AM-694 chloro derivative. Its 
base peak is the peak at m/z 248, which has more 34Da than m/z 214. Thus, 
assuming that the substitution comprises a chlorine atom, this difference makes 
sense, has it will gain 35Da from the chlorine atom and lose and hydrogen atom 
(Figure 66). 
 
Figure 66 - Fragmentation of AM-694 chloro derivative, forming the base peak at m/z 248 
 The presence of a chlorine atom in the molecule can also be considered 
due to the presence of characteristic peaks that show the isotope ratio of the 
chlorine atom. Hence, the isotopic pattern of chlorine translates into two peaks, 
m/z 250 (m/z 248 + 2) and m/z 453 ([M+] +2) with approximately 30% of the 
abundance of their parent ions. This phenomenon is characteristic of chlorine, 
since it represents the 37Cl isotope, 30% abundant when compared to the 35Cl 
isotope [35, 48]. 
 As seen in the fragmentation of other compounds, the loss of the 
substitution in the indole group is plausible to occur. In the case of these two 
compounds, as the difference between them is in this substitution, the loss of it 
would lead to fragments of the same mass in the MS of both compounds. 
Hence, two peaks can be analysed, m/z 360 (C16H11NIO+) and m/z 220 
(C15H10NO+) [89]. The formation of both fragments is proposed in Figure 67. 
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Taking into account the relative abundancies of both fragments, it could 
be suggested that the loss of the iodine atom is more plausible to occur, as 
peak m/z 220 (C15H10NO+) is very abundant in both compounds. 
 
Figure 67 - Fragments m/z 360 and m/z 220, common to AM-694 and AM-694 chloro derivative 
 
The final two compounds identified in this initial analysis by GC-EI-MS 
are AM1248 and AKB-48. According to this analysis, they have in common and 
adamantyl moiety on one of the sides of the carbonyl group. AM1248 was first 
reported to the EWS in 2012 by Germany [26] and, to the best of our 
knowledge, its identification was first reported by Uchiyama et al in 2012 [90]. 
The EI-MS of AM1248 reveals the presence of an abundant base peak at m/z 
98. Considering the structure of the compound, α-cleavage is possible to occur 
between the piperidine group and the indole moiety, with charge being retained 
on the piperidine group, hence the peak at m/z 98 (C6H12N+) (Figure 68). 
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Figure 68 - EI-MS of AM1248 
 This is consistent with the literature as the same peak has been reported 
in studies on compounds with the presence of this group [90], [91], [92]. Due to 
the high intensity of the base peak, all the other peaks are not much abundant, 
but some of them are rather important in the analysis of the compound. The 
molecular ion is present [m/z 390 (C26H34N2O+)] as well as ions characteristic of 
the adamantyl group [m/z 135 (C10H15+)] and also the ion formed via α-cleavage 
as well, but not as prominent as m/z 98, m/z 292 (C20H22NO+) [90]. However, 
despite the fact that an indole moiety is present, the characteristic peaks 
mentioned before, m/z 214 (C24H16NO+) and m/z 144 (C9H6NO+), are not 
present, quite possibly due to the very low abundances of these peaks in the EI-
MS of this compound. Again, other compounds with the piperidine group 
attached to an indole group do not show the characteristic peaks of an indole 
moiety [91]. 
 AKB-48 is a synthetic cannabinoid that belongs to the family of the 
adamantoylindazoles, i.e., it has an indazole moiety, on the contrary of the other 
compounds discussed up to this point. This compound was first reported in the 
literature by Uchiyama et al in 2012 [90], under the name APINACA, and was 
reported in the EU in May 2012 [26]. Curiously, this compound got his current 
name, AKB-48, from a Japanese girl band, probably for marketing purposes 
[26]. Its EI-MS shows a great range of peaks with different abundancies (Figure 
69). The presence of a carboxamide as the linking group between the two 
moieties gives rise to its base peak, resultant from cleavage of the C-N bond 
[48] and characteristic of a pentyl-substituted indazole group, m/z 215 
(C13H15N2O+). The fact that this peak is characteristic of an indazole group can 
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be derived from the characteristic peak of an indole, m/z 214 (C14H16NO+). The 
difference between indazole and indole groups is the addition of a nitrogen 
atom (14Da) and the loss of a carbon and hydrogen atoms (13Da). 
 
 
Figure 69 - EI-MS of AKB-48 
Alike, the presence of fragments m/z 145 (C8H5N2O+) and m/z 117 
(C7H5N2+) are characteristic of an indazole moiety. The presence of the 
adamantyl group and the carboxamide linker can be assessed by peaks m/z 
135 (C10H15+), as seen for AM1248 (Figure 70) and m/z 150 (C10H16N+), 
resulting from cleavage of the C-N bond on the carboxamide group, with charge 
retained on the nitrogen atom attached to the adamantyl group (Figure 70). 
 
Figure 70 - Indazole and Adamantyl fragments of AKB48: Comparison with fragmentation of 
UR-144 nad AM1248 
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 This initial GC-EI-MS analysis of herbal incenses permitted the 
identification of 10 different synthetic cannabinoids (Figure 71) in 23 different 
herbal incense products. This analysis served as an indicator of the possible 
content of the packages and was useful as a screening tool for the second part 
of this project. The EI-MS spectra analysis allowed the identification of 
characteristic fragments that could be used in further analysis, especially if a 
new compound emerges. 
 
Figure 71 - Synthetic Cannabinoids detected in the Preliminary GC-EI-MS analysis 
3.2.2. Isolation of Compounds from Herbal Incenses 
After the preliminary analysis, new samples were chosen according to 
the possible contents verified by the first analysis, in order to characterise the 
compounds by NMR in order to add synthetic cannabinoids to the in-house EI-
MS library. Due to the complexity of the samples, i.e., due to the fact that they 
are present in an herbal matrix, an isolation process by liquid chromatography 
was first employed, in order to have the compounds in a pure form to be 
characterised by NMR, as to confirm the presence of the compounds previously 
analysed by GC-MS. Therefore, based on the results shown in Table 14, 
samples of Esfinge, Magic, Maya2012, Spike 99, Spliff and Radioactive were 
chosen in order to isolate all the synthetic cannabinoids previously detected by 
GC-EI-MS in herbal incenses (Figure 71). At least two packages of each 
product were chosen and were firstly analysed by GC-EI-MS to check if the 
composition was the same (Table 15). 
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Table 15 - Composition of the analyses on herbal incenses with the same brand name 
Product First GC-MS Second GC-MS 
Sample Result 
Esfinge JWH-210 
1 JWH-210 
2 JWH-210 
Magic JWH-018 
1 JWH-018 
JWH-122; 
2 
JWH-018 
MAM2201 
Maya2012 
UR-144 
AKB-48 
1 
UR-144 
AKB-48 
2 
XLR-11 
AKB-48 
Spliff 
JWH-250 
JWH-122 
1 
JWH-250 
JWH-122 
2 JWH-250 
3 - 
4 - 
5 - 
Spike99 
5-MeO-DALT 
AM694 
JWH-122 
Cl-AM694 
AM1248 
1 
5-MeO-DALT 
AM694 
JWH-122 
Cl-AM694 
AM1248 
2 
3 
4 
5 
Radioactive 
5-MeO-DALT 
AM694 
JWH-122 
Cl-AM694 
AM1248 
1 
5-MeO-DALT 
AM694 
JWH-122 
Cl-AM694 
AM1248 
2 
3 
4 
5 
 
As seen in Table 15, different packages of the same brand name 
revealed the presence of different compounds, thus indicating a possible 
variability within the products. From the new detected compounds, one has not 
been detected in the previous analysis. 
XLR-11, or 5F-UR-144, is the fluor derivative of UR-144 and was first 
reported to the EWS in February 2012, by Latvia [26]. To the best of our 
knowledge, the first time that the occurrence of XLR-11 in herbal incenses was 
reported in the literature was in 2013 by Choi et al [81]. Figure 72 shows the EI-
MS spectrum of XLR-11.  
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Figure 72 - EI-MS of XLR-11, the 5-pentyl fluorinated analogue of UR-144 
As seen in the comparison between JWH-122 and MAM-2201, the 
comparison of fragmentations between XLR-11 and UR-144 can facilitate the 
identification of this compound (Figure 73). 
 
 
 
 
 
 
 
Figure 73 - Comparison of Fragments of UR-144 and XLR-11 
As seen in other cases, the fluor substitution on the aliphatic chain 
increases all the correspondent peaks in 18Da. Therefore, the characteristic 
peaks of the indole moiety where fluor is present are the base peak m/z 232 
(C14H15FNO+), result from α-cleavage and the base peak m/z 329 
(C21H28FNO+). 
Again, the presence of possible characteristic peaks of the tetramethyl-
substituted cyclopropane moiety are not present, due to its facile thermal 
degradation [83]. Nonetheless, as observed in UR-144, this compound also 
reveals the presence of its cyclopropyl rearrangement product, therefore 
allowing for a more correct identification of the compound. 
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All the characteristic peaks from the EI-MS of the rearrangement product 
are the same as the ones observed for XLR-11 [81]. Anyway, as observed in 
UR-144, the cyclopropyl rearrangement product has a second peak, adjacent to 
the base peak, with a 15Da increase, leading to fragment m/z 247 
(C15H18FNO+), which results from rearrangement on the cyclopropyl, followed 
by cleavage [81] (Figure 74). 
 
 
Figure 74 - EI-MS of the cyclopropyl rearrangement product of XLR-11 
 After all the compounds were identified by EI-MS, methanolic extraction 
of the herbal incense products was performed in order to isolate the synthetic 
cannabinoids of interest by liquid chromatography. The purified NPS were then 
identified by NMR spectroscopy. 
3.2.3. NMR Analyses of Isolated Synthetic Cannabinoids 
Three synthetic cannabinoids were isolated from their matrix by liquid 
chromatography and the purified compounds were analysed by NMR. From the 
methanolic extract of herbal incense product Magic (lote ‘2012 43XMGO’, 
smartshop H) were isolated Compound 1 and Compound 3, and from product 
Esfinge (lote 2012 43X28M, smartshop H), Compound 2. All three synthetic 
cannabinoids were identified by GC-EI-MS analysis as JWH-018 (Compound 
1), JWH-122 (Compound 3) and JWH-210 (Compound 2). 
Analysis of 1H NMR spectrum of Compound 1 in CDCl3 revealed the 
presence of 23 protons: a methyl signal at δ0.86 (3H, t, J = 6.80Hz); three 
methylene signals at δ1.25 (2H, m, overlapped), δ1.29 (2H, m, overlapped) and 
δ1.81 (2H, m, J = 7.20Hz); a methylene signal connected to a nitrogen atom at 
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δ4.07 (2H, t, J = 7.20Hz) and 12 aromatic signals at δ7.36 (1H, s), δ7.37 (1H, 
m, overlapped), δ7.37 (1H, m, overlapped), δ 7.39 (1H, overlapped), δ7.47 (1H, 
m, overlapped), δ7.51 (1H, m, overlapped), δ7.53 (1H, m, overlapped), δ7.67 
(1H, d, J = 6.40Hz), δ 7.92 (1H, d, J = 7.60Hz), δ 7.97 (1H, d, J = 8.00Hz), δ 
8.20 (1H, d, J = 8.00Hz) and δ 8.51 (1H, m, overlapped). 
13C APT NMR spectrum revealed the presence of 24 carbons, 
suggesting a carbonyl carbon at δ 192.00, 6 aromatic quaternary carbons 
(δ117.46, δ126.94, δ130.74, δ133.68, δ136.98 and δ139.04), 12 aromatic 
methine carbons (δ109.96, δ122.81, δ122.87, δ123.56, δ124.52, δ125.80, 
δ125.95, δ126.25, δ126.71, δ128.12, δ129.92 and δ137.95), 1 methylene with a 
nitrogenated carbon (δ47.13), 3 methylene carbons (δ22.13, δ28.85 and 
δ29.44) and 1 methyl carbon at δ13.84. 
The assignment off all signals was permitted by using 1D and 2D 
correlation techniques, as seen in Figure 75 and Table 16. 
 
Figure 75 – Key COSY and HMBC correlations in Compound 1 
Attribution of the signals for Compound 1 started with the aliphatic 
signals, from the terminal methyl group (δH0.86t/ δC13.84) to the N-CH2 group 
(δH4.07t/ δC47.13). Using the two-dimensional (2D) correlation NMR techniques 
COSY (homonuclear 1H-1H) and HMBC (heteronuclear 1H-13C), it was 
possible to determine the position of the others 3 methylene groups (δH1.25m/ 
 
 
         COSY 
 
 
         HMBC 
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δC28.85; δH1.29m/ δC22.13; δH1.82m/ δC29.44) on the aliphatic chain (Figure 
76). 
 
Figure 76 - Selected correlations for the aliphatic chain of Compound 1 by COSY and HMBC 
The COSY correlations (between the methylene at δH1.29 and the 
terminal methyl at δH0.86 ((C5’’’), and between the methylene at δH1.81 and N-
CH2 at δH 4.07 (C1’’’)), and the HMBC correlations (between the proton signal of 
N-CH2 and the carbons δC28.85/δC 29.44, and between the terminal methyl and 
the carbons δC28.82/ δC22.13), allowed for the correct attribution of signals at 
2’’’, 3’’’ and 4’’’ positions (Figure 76). The HMBC correlations of HC1’’’ with the 
methine carbon δC137.95 and the quaternary carbon δC139.98 enabled the 
assignment of the NMR signals at positons 2’ and 7’a, respectively. The 
aromatic proton δH7.67d (125.80) was assign to C2’’ by its HMBC correlation 
with the carbonyl C1. 
The C4’’ (δC 129.92) was confirmed with HMBC correlations with 5’’, 8’a 
and 2’’. H5’’ also showed a COSY correlation with H6’’, which revealed a HMBC 
correlation with C8’’. H8’’ showed a COSY correlation with the missing aromatic 
proton, H7’’ and HMBC correlation with a quaternary carbon (δC 133.68), 
assigned as 4’’a. 
At this point, there are 3 quaternary carbons left to assign. HMBC 
allowed for the attribution of C1’’, due to a correlation with H8’’. C3’ and C3’a 
with value of δC117.46 and δC126.94 showed HMBC correlations with aromatic 
protons of the indole moiety, and comparison with the literature of other indole 
cannabinoids revealed the expected values for this carbons (117.45-117.6; 127-
127) leading to their attribution [93, 79, 70, 80].  The HMBC correlations of C3’ 
with the indole proton at 8.51m ppm means that it must be the H4’. The other 
aromatics carbons where assigned by HMBC correlations between C4’ and H6’ 
and between C5’ and H7’ (also confirmed by existing literature) [93, 79, 70, 80]. 
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Table 16 - 1H and 13C NMR data of Compound 1 and JWH-018 (from literature) 
Position JWH-018 [93] Compound 1 
13C HSQC 13C HSQC 
1 192.0 - 192.00 - 
2’ 137.9 7.33s 137.95 7.36s, 1H 
3’ 117.5 - 117.46 - 
3’a 127.0 - 126.94 - 
4’ 122.9 8.47m 122.87 8.51m, 1H, 
overlapped 
5’ 122.8 7.35m 122.81 7.37m, 1H, 
overlapped 
6’ 123.6 7.35m 123.56 7.37m, 1H, 
overlapped 
7’ 110.0 7.38m 109.96 7.39m, 1H, 
overlapped 
7’a 137.0 - 136.98 - 
1’’ 139.1 - 139.04 - 
2’’ 125.8 7.64dd 125.80 7.67d, 1H J = 6.40Hz 
3’’ 124.5 7.51dd 124.52 7.53m, 1H, 
overlapped 
4’’ 129.9 7.95brd 129.92 7.97d, 1H, J = 8.00Hz 
4’’a 133.7 - 133.68 - 
5’’ 128.1 7.90brd 128.12 7.92d, 1H, J = 7.60Hz 
6’’ 126.3 7.50td 126.25 7.51m, 1H, 
overlapped 
7’’ 126.7 7.45ddd 126.71 7.47m, 1H, 
overlapped 
8’’ 126.0 8.17brd 125.95 8.20d, 1H, J = 8.00Hz 
8’’a 130.8 - 130.74 - 
1’’’ 47.2 4.05t 47.13 4.07t, 2H, J = 7.20Hz 
2’’’ 29.5 1.79quint 29.44 1.81m, 2H, J = 
7.20Hz 
3’’’ 28.9 1.24m 28.85 1.25m, 2H, 
overlapped 
4’’’ 22.2 1.28m 22.13 1.29m, 2H, 
overlapped 
5’’’ 13.8 0.83t 13.84 0.86t, 3H, J = 6.80Hz 
 
The signal attribution of unknown compound 1 and its comparison with a 
published attribution of JWH-018 can be seen in Table 16. Therefore, 
Compound 1 was elucidated as JWH-018, as predicted by the EI-MS analysis. 
 As seen in the MS analysis, Compounds 2 and 3 could respectively be 
JWH-210 and JWH-122. Structurally, they differ from JWH-018 by the presence 
of an ethyl group or a methyl group, respectively, on the naphthalene moiety. 
Hence, it should be simple to assign to elucidate the structures of Compound 2 
and 3 by comparing their NMR spectra with the spectra of Compound 1. 
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 The 1H NMR spectra of Compound 2 and Compound 3 revealed the 
presence of extra alkyl signals, two for Compound 2 (3.19q; 2H; J=7.20Hz and 
0.86t; 3H; J=7.20Hz, characteristic of an ethyl group) and one for Compound 3 
(2.78s; 3H characteristic of a methyl group) (Figure 77). Also, in the low field 
region (or aromatic region) is possible to see the influence of the alkyl groups 
on the chemical shifts of the aromatic protons (Figure 78). 
 5’’  2’’’ 
Figure 77 - Comparison of High Field 1H NMR Spectra of JWH-018 (black), Compound 3 (blue) 
and Compound 2 (red) 
Compound 
2 
Compound 
3 
 JWH-018 
 5’’ 
 5’’ 
 2’’ 
 1’’’ 
 1’’ 
 1’’ 
 2’’ 
 3’’/4’’ 
 2’’ 
 1’’’  1’’ 
 3’’/4’’ 
 3’’/4’’ 
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Figure 78 - Comparison of Low Field 1H NMR Spectra of JWH-018 (black), Compound 3 (blue) 
and Compound 2 (red) 
The 13C NMR of Compound 2 showed the presence of an extra methyl 
carbon (δC 14.90) and an extra methylene carbon (δC 26.17) and Compound 3 
revealed the presence of an extra methyl carbon (δC 19.79). All this is in 
accordance with the possible matches of JWH-210 and JWH-018 for 
Compounds 2 and 3, respectively [75, 74]. 
Table 17 shows the comparison of attributed signals of all three 
compounds and respective literature on JWH-018, JWH-210 and JWH-122. 
 
Compound 
2 
Compound 
3 
JWH-018 
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Table 17 - NMR Assignments of Compounds 1, 2 and 3 and respective comparison with the literature 
Position JWH-210 [70] Compound 2 JWH-122 [70] Compound 3 JWH-018 [93] Compound 1 
13C 1H 13C HSQC 13C 1H 13C HSQC 13C 1H 13C HSQC 
1 192.3 - 192.30 - 192.3 - 192.00 - 192.0 - 192.00 - 
2` 137.5 7.37s 137.90 7.38m 137.9 7.37brs 137.79 7.38s 137.9 7.33s 137.95 7.36s 
3` 117.7 - 117.60 - 117.8 - 117.68 - 117.5 - 117.46  
3a` 127.1 - 127.01 - 127.2 - 127.04 - 127.0 - 126.94  
4` 123.0 8.49m 122.9 8.49 122.9 8.49m 122.74 8.49m 122.9 8.47m 122.87 8.51m 
5` 122.7 7.35m 122.74 7.35 123.1 7.36m 122.92 7.37m 122.8 7.35m 122.81 7.37m 
6` 123.8 7.35m 123.49 7.35 123.6 7.36m 123.49 7.37m 123.6 7.35m 123.56 7.37m 
7` 109.9 7.39m 109.9 7.40 110.0 7.39m 109.91 7.39m 110.0 7.38m 109.96 7.39m 
7a` 137.0 - 137.0 - 137.1 - 137.01 - 137.0 - 136.98 - 
1” 137.8 - 137.42 - 137.7 - 137.56 - 139.1 - 139.04  
2” 125.9 7.59brd 125.91 7.60d 125.9 7.57brd 125.80 7.56d 125.8 7.64dd 125.80 7.67d 
3” 123.5 7.38m 123.49 7.39 125.4 7.38m 125.25 7.38m 124.5 7.51dd 124.52 7.53m 
4” 142.5 - 142.5 - 136.7 - 136.62 - 129.9 7.95brd 129.92 7.97d 
4a” 132.0 - 132.0 - 132.9 - 132.80 - 133.7 - 133.68  
5” 125.8 8.13d 123.8 8.14d 124.3 8.08brd 124.18 8.08d 128.1 7.90brd 128.12 7.92d 
6” 126.2 7.54td 126.06 7.55t 126.2 7.56td 126.11  126.3 7.50td 126.25 7.51m 
7” 126.8 7.46td 126.21 7.47t 126.5 7.48ddd 126.36 7.49m 126.7 7.45ddd 126.71 7.47m 
8” 126.0 8.25d 126.75 8.26d 126.7 8.25brd 126.61 8.25d 126.0 8.17brd 125.95 8.20d 
8a” 131.2 - 131.10 - 131.0 - 130.89 - 130.8 - 130.74  
1’’’ 47.1 4.07t 47.12 4.07t 47.2 4.07t 47.12 4.06t 47.2 4.05t 47.13 4.07t 
2’’’ 29.5 1.80quint 29.47 1.81m 29.6 1.82quint 29.46 1.81m 29.5 1.79quint 29.44 1.81m 
3’’’ 28.9 1.26m 28.87 1.26m 29.1 1.32m 28.89 1.27m 28.9 1.24m 28.85 1.25m 
4’’’ 22.2 1.28m 22.15 1.29m 22.3 1.27m 22.15 1.31m 22.2 1.28m 22.13 1.29m 
5’’’ 13.8 0.85t 13.81 0.86t 14.0 0.86t 13.83 0.86t 13.8 0.83t 13.84 0.86t 
1’’’’ 26.2 3.18quartet 26.17 3.19q 19.9 2.79s 19.79 2.78s - - - - 
2’’’’ 14.9 1.44t 14.90 1.45t - - - - - - - - 
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 The preliminary GC-EI-MS analysis of 33 herbal incenses allowed the 
detection and identification of 10 synthetic cannabinoids (JWH-018, JWH-122, 
JWH-210, JWH-250, MAM2201, AKB48, UR-144, AM694, AM694-chloro 
derivative and AM1248). A second GC-EI-MS analysis of products that 
contained only one or two synthetic cannabinoids was performed, as to verify 
the composition of the packages and also check for the possible existence of 
different compounds. Through this, it was possible to identify MAM2201 in a 
different package and XLR-11, a new compound that was not detected during 
the preliminary analysis. From the 11 identified cannabinoids, only 7 were until 
now isolated by our group. The 3 naphthoylindole cannabinoids, JWH-018, 
JWH-122 and JWH-210 were isolated from Esfinge and Magic products in the 
scope of this project. The 4 synthetic cannabinoids (AKB48, UR-144, XLR-11 
and MAM2201) detected in herbal incense samples were purified and identified 
trough NMR spectroscopy by Carlos Branco, within his project, and by 
Christophe Gonçalves, within his ERASMUS internship. The analysis of herbal 
incenses and subsequent isolation and characterisation of those compounds by 
NMR allowed the unequivocal identification of the 7 synthetic cannabinoids as 
predicted by the EI-MS analysis. 
All these seven Isolated and characterised compounds were then 
analysed by GC-EI-MS by the method recommended by the UNODC, in order 
to create an in-house EI-MS library of synthetic cannabinoids. Table 18 shows 
the GC-EI-MS characteristics of the seven purified compounds. 
Table 18 - In-house EI-MS library of 7 synthetic cannabinoids 
Compound Rt (min) Base Peak Other EI Fragmentations 
JWH-210 16.2 369 [M+] 312, 298, 214, 183, 144 
JWH-018 14.1 341 [M+] 284, 270, 214, 155, 144, 127 
JWH-122 15.6 355 [M+] 298, 284, 214, 169, 144, 141 
MAM2201 17.2 373 [M+] 298, 284, 232, 144, 141, 115 
AKB-48 13.6 215 365 [M+], 308, 294, 187, 135 
XLR-11 8.3 232 329 [M+], 314, 144 
UR-144 7.0 214 311 [M+], 144 
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3.2.4. SGT-25: A novel cannabinoid in a seized sample 
As seen in the case of 4F-PBP, the collaboration between FCUL and 
LPC/PJ also allows the assistance of the faculty in the identification of novel 
substances that may arise within the casework of the toxicology sector at 
LPC/PJ. A yellowish oil was seized and in its packaging, the following label was 
present: “1(5-fluoropentyl)-N-2-phenylpropan-2-yl)indazole-3-carboxamide”. 
This label suggests a chemical structure, as see in Figure 80. 
 
Figure 79 - Chemical structure of SGT-25 
 A sample of the yellowish oil was analysed by GC-MS and its analysis 
revealed the presence of an unknown compound, even after comparison with 
the existing MS libraries, like SWGDRUG, ENFSI or Cayman. This is due to the 
fact that this compound was just reported for the first time in 2014.The sample 
was analysed by GC-EI-MS and the resulting MS is shown in Figure 80. 
 
 
 
Figure 80 - EI-MS of SGT-25 
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As expected considering the structure of the compound, its base peak is 
not its molecular ion, as the compound undergoes α-cleavage, originating a 
base peak at m/z 233 (C13H14FN2O+). Considering its indazole moiety, 
comparison of this result can be made with AKB-48, another indazole-type 
synthetic cannabinoid discussed earlier. The fluor substitution on the indazole 
can be assessed by the base peak of SGT-25. In AKB48, with a pentyl-
substitution on the indazole group, the base peak is m/z 215 (C13H15N2O+). As 
discussed earlier, the presence of a fluor atom will increase a fragment mass in 
18Da. Accordingly, the difference of the base peaks of the two compounds is 
18Da (m/z 232 – m/z 215 = 18Da), thus confirming it fluor-substitution. Peak at 
m/z 145 also indicates the presence of an indazole group, again, as seen for 
AKB48 (Figure 81). 
 
Figure 81 - EI-MS fragmentations of the Indazole moiety of SGT-25 and AKB48 
The presence of a benzyl group on the other side of the carboxamide 
group is estimated by the presence of fragment m/z 91 (C7H7+), the tropiylium 
ion characteristic of phenylalkanes, as seen in the case of 4-MEC [32, 35], 
However, the substitution of a cumyl group can be assessed by other peaks, at 
m/z 119 (C9H11+), resulting from cleavage from the carboxamide group Figure 
82). 
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Figure 82 - EI-MS fragmentation of SGT-25 on the cumyl moiety 
 After analysis by GC-MS, the sample was analysed at FCUL by NMR in 
CDCl3. 
 Analysis of the 1H NMR spectrum of SGT-25 in CDCl3 revealed the 
presence of 26 protons: two methyl signals at δ1.87 (6H, s); three methylene 
signals at δ1.48 (2H, m, J=7.6Hz), δ1.75 (2H, dq) and δ2.01 (2H, m, J=7.6Hz); 
a methylene signal connected to a nitrogen atom at δ4.40 (2H, t, J = 7.2Hz); a 
methylene signal geminal to a fluor atom at δ4.43 (2H, dt, J=47.2Hz) and seven 
aromatic protons at δ7.21 (1H, m, overlapped), δ7.23 (1H, t, overlapped), δ7.34 
(2H, t, J=7.6Hz), δ7.39 (1H, m, overlapped), δ7.39 (1H, m, overlapped), δ7.52 
(2H, d, J=8.0Hz) and δ8.34 (1H, d, J=8.0Hz). 
13C NMR spectrum revealed the presence of 22 carbons, suggesting a 
carbonyl carbon at δ161.00, four aromatic quaternary carbons at δ122.76, 
δ137.80, δ140.81 and δ147.17; one quaternary carbon coupled to two 
methylene groups at δ55.75; nine aromatic carbons at δ108.95, δ122.38, 
δ123.18, δ124.80 (2 carbons), δ126.53, δ126.68, δ128.38 (2 carbons); one 
methylene carbon attach to a nitrogen atom at δ49.04; three methylene carbons 
at δ22.65 (d, J=5.0Hz), δ29.31 and δ29.86 (d, J=19.72Hz); one methylene 
carbon coupled to a fluor atom at δ83.66 (d, J=164.80) and two methyl carbons 
at δ29.56. 
Assignment of each carbon to the corresponding protons was possible 
with HSQC correlations (Table 19) 
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Figure 83 - Key COSY and HMBC correlations for SGT-25 
Attribution of the signals for SGT-25 started with the methyl groups at 
δH1.87s which revealed the presence of 6 protons, correspondent to the two 
equivalent methyl groups at C2’’a. HMBC correlation of this proton signal with 
δC55.75 and δC 147.17 allowed the assignment of two quaternary carbons 2’’ 
and 3’’, respectively. HMBC correlations of C2’’ with the aromatic protons 
δH7.52d permitted the attribution of the chemical equivalent aromatic signals at 
positions 4’’ and 8’’ (δH7.52d/ δC 124.8). The COSY correlations of these 
aromatic protons with the signal δH7.34t (2H), which also had a COSY 
correlation with δH7.34t (2H), 7.23t (1H) allowed the correct assign of the 
aromatic signals at 5’’/7’’/6’’ positon (Figure 83). 
The aliphatic chain was attributed due to the characteristic carbons at 
δ49.04 of a N-CH2 (1’’’) group and at δ83.66 (d, J=164.80) of a carbon linked 
directly to a fluor atom. COSY correlations between each proton and its 
neighbour allowed for the correct attribution of signals 1’’’ to 5’’’ of the aliphatic 
chain (Figure 84). 
 
Figure 84 - Key COSY correlations in the aliphatic chain of SGT-25 
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Table 19 - 1H and 13C signals for SGT-25 in CDCl3 
Position 13C, J (Hz) 1H; J (Hz) 
1 161.75 - 
2’ 137.80 - 
3’a 122.76 - 
3’ 123.18 8.34, d, 1H, 8.0 
4’ 122.38 7.21, m, 1H 
5’ 126.68 7.39, m, 1H 
6’ 108.95 7.39, m, 1H 
6’a 140.81 - 
2’’ 55.75 - 
2’’a 29.56 1.87, s, 6H 
3’’ 147.17 - 
4’’/8’’ 124.80 7.52, d, 2H, 8.0 
5’’/7’’ 128.38 7.34, t, 2H, 7.6 
6’’ 126.53 7.23, m, 1H 
1’’’ 49.04 4.40, t, 2H; 7.2 
2’’’ 29.31 2.01, m, 2H,  
3’’’ 22.65d, 5.0 1.48, m, 2H 
4’’’ 29.86d, 19.7 1.75, m, 2H;  
5’’’ 83.66d, 164.8 4.43, dt, 2H, 47.2; 6.0 
 
The δC140.81 was assigned to C6’a by its HMBC correlation with H1’’’. 
The HMBC correlation with the aromatic proton at δH8.34d with 3 quaternary 
carbons (δC140.81, 122.76 and 137.80) allowed the attribution of H3’ (δH 8.34), 
C3’a (δC122.76) and C2’ (δC137.8). The other 3 aromatic signals were assigned 
by COSY correlations. between H3’ and H4’ and also by HMBC correlations of 
H3’ with C4’. 
 Analytical data from EI-MS and NMR allowed the confirmation of the 
unknown compound as SGT-25 and also allowed the addition of this compound 
to the EI-MS library of NPS. The 1H NMR values are in accordance with the 
only published reference of this compound, although not assigned [94]. SGT-25 
is a novel NPS and, there is a lack of analytical information available in the 
literature. Therefore, SGT-15 was analysed by NMR in different solvents: 
CDCl3, benzene-d6, DMSO and MeOD. 1H and 13C signals in all four solvents 
are shown in Table 20. 
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Table 20 - 1H and 13C NMR Signals of SGT-25 in CDCl3, MeOD, Benzene-d6 and DMSO 
Position 
 
CDCl3 MeOD Benzene-d6 DMSO  Position 
 
CDCl3 MeOD Benzene-d6 DMSO 
13C, J (Hz) 13C, J (Hz) 13C, J (Hz) 13C, J (Hz)   1H, m J (Hz) 1H, m, J (Hz) 1H, m, J (Hz) 1H, m, J (Hz) 
1 161.75 163.94 161.66 161.10  1 - - - - 
2’ 137.80 138.59 139.00 137.28  2’ - - - - 
3’a 122.76 123.79 123.65 121.99  3’a - - - - 
3’ 123.18 123.13 124.08 121.78  3’ 8.34, d, 1H, 
8.0 
8.10, d, 1H, 
8.2 
8.84, d, 1H; 
8.0 
8.05, 1H, d, 
8.4 
4’ 122.38 123.66 122.73 122.28  4’ 7.21, m, 1H 7.22, t, 1H, 
8.0 
7.03, t, 1H; 
7.2 
7.22, 1H, t, 
7.6 
5’ 126.68 127.94 126.79 126.55  5’ 7.39, m, 1H 7.42, t, 1H, 
7.5 
7.09, t, 1H; 
7.2 
7.43, 1H, m 
6’ 108.95 110.93 109.07 110.35  6’ 7.39, m, 1H 7.61, d, 1H, 
8.6 
6.90, d, 1H; 
8.4 
7.78, 1H, d, 
8.4 
6’a 140.81 142.41  141.24  140.58   6’a - - - - 
2’’ 55.75 57.00 55.95 55.15  2’’ - - - - 
2’’a 29.56 30.04 29.41 29.53  2’’a 1.87, s, 6H 1.81, s, 6H 1.76, s, 6H 1.73, 6H, s 
3’’ 147.17 148.51 147.91 147.71  3’’ - - - - 
4’’/8’’ 124.80 125.91 125.32 124.78  4’’/8’’ 7.52, d, 2H, 
8.0 
7.48, d, 2H, 
7.7 
7.48, d, 2H, 
7.6 
7.43, 1H, m 
5’’/7’’ 128.38 129.36 128.60 128.03  5’’/7’’ 7.34, t, 2H, 7.6 7.31, t, 2H, 
7.5 
7.16, m, 2H,  7.30, 2H, t, 
7.6 
6’’ 126.53 127.46 126.70 125.98  6’’ 7.23, m, 1H 7.20, t, 1H, 
8.0 
7.06, m, 1H 7.19, 1H, t, 
7.6 
1’’’ 49.04 50.08 48.85 48.51  1’’’ 4.40, t, 2H; 7.2 4.51, t, 2H, 
7.0 
3.80, 2H, t, 
7.1 
4.52, 2H, t, 
6.8 
2’’’ 29.31 30.44 29.37 29.08  2’’’ 2.01, m, 2H,  2.01, m, 2H 1.50, 2H, m 1.93, 2H, m 
3’’’ 22.65, d, 5.0 23.70, d, 5.1 22.66, d, 5.0 22.07, d, 5.2  3’’’ 1.48, m, 2H 1.44, m, 2H 1.00, 2H, m 1.37, 2H, m 
4’’’ 29.86, d, 19.7 31.00, d, 19.8 29.95, d, 19.8 29.34, d, 19.1  4’’’ 1.75, m, 2H;  1.72, m, 2H 1.17, 2H, m 1.65, 2H, m 
5’’’ 83.66, d, 164.8 84.67, d, 163.9 83.19, d, 166.1 83.67, d, 161.7  5’’’ 4.43, dt, 2H, 
47.2; 6.0 
4.40, dt, 2H, 
47.5; 6.0 
3.92, 2H, dt, 
47.6; 6.0 
4.42, 2H, dt, 
47.5; 6.0 
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The analysis of 54 samples of herbal incenses (33 herbal incenses for 
the preliminary GC-EI-MS, 20 products for the second GC-EI-MS analysis and 1 
seized sample) has allowed the construction of an in-house EI-MS library of 8 
synthetic cannabinoids (JWH-018, JWH-122, JWH-210, AKB48, UR-144, XLR-
11, MAM2201 and SGT-25). Again, the construction of an in-house library is of 
great importance for a routine laboratory, as the thorough study of the 
spectrometric and fragmentation behaviour of these compounds may aid in the 
discovery of novel NPS and in the continuous monitoring of already existing 
substances. This study has allowed for the identification of specific EI-MS 
fragments of some characteristic groups usually present in synthetic 
cannabinoids, with the advantage of having a Rt associated. The developed 
methodology allowed the characterisation of a recently reported compound in 
the EU, SGT-25, not yet reported in the literature. 
From this analyses, only 12 synthetic cannabinoids were detected and 
analysed. However, more than 100 have already been reported in the EU [65]. 
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3.3. Final In-House EI-MS Library of NPS 
From products of the voluntary deliveries and seized samples, it was possible to 
obtain 12 synthetic cathinones (Figure 85 and Table 21) and 8 synthetic cannabinoids 
(Figure 86 and Table 22) used to build an in-house EI-MS library of NPS. This is very 
relevant, as, otherwise, these products would have probably ended up destroyed, 
meaning that this methodology allows the avail of street products, turning them into 
secondary standards. 
 
Figure 85 - EI-MS Library of Synthetic Cathinones 
 
Table 21 - EI-MS Library of Synthetic Cathinones 
Compound Rt (min) Base Peak Other Relevant Fragmentations 
3,4-DMMC 10.55 58 191 [M+], 133, 105, 77 
4F-PBP 11,25 112 233, 123, 95 
4-MEC 9.81 72 191 [M+], 119, 105, 91, 77, 65, 44, 39 
Buphedrone 8.59 72 148, 105, 77, 57, 44 
Ethylphenidate 12.56 84 146, 91, 77 
Flephedrone 7.60 58 166, 123, 95, 75 
Mephedrone 9.09 58 119, 105, 91 
Methedrone 11.07 58 178, 135, 107 
Methylone 12.14 58 207 [M+], 149, 121, 42 
MDPBP 15.21 112 260 [M+], 232, 149, 121, 86, 55, 41 
MDPV 15.67 126 273, 232, 149, 86, 65, 41 
N-ethylcathinone 8.48 72 105, 77, 44 
Pentedrone 9.55 86 105, 77, 44, 51, 39 
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Figure 86 - EI-MS Library of Synthetic Cannabinoids 
 
Table 22 - EI-MS Library of Synthetic Cannabinoids 
Compound Rt (min) Base Peak Other EI Fragmentations 
JWH-210 16.2 369 [M+] 312, 298, 214, 183, 144 
JWH-018 14.1 341 [M+] 284, 270, 214, 155, 144, 127 
JWH-122 15.6 355 [M+] 298, 284, 214, 169, 144, 141 
MAM2201 17.2 373 [M+] 298, 284, 232, 144, 141, 115 
AKB-48 13.6 215 365 [M+], 308, 294, 215, 145 
XLR-11 8.3 232 329 [M+], 314, 144 
UR-144 7.0 214 311 [M+], 144 
SGT-25 11.1 233 367 [M+], 352, 145 
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4. Conclusions 
In the past decade, there has been an uprising on the availability and spread of 
NPS, substances commercialised with the intention to mimic the effects of illicit drugs, 
but that fall outside the scope of international and national drug control all over the 
world. 
Since 2008, more than 450 NPS have been reported in the EU alone, making it a 
serious challenge for forensic practitioners to analyse these compounds, as appropriate 
methods and standards are either too expensive or hard to get. In Portugal, since 2013 
that this topic has become of the greatest importance for forensic toxicologists, with the 
implementation of Dec Lei 54/2013, of 17th April, which forbids the commercialisation 
and production of about 149 substances, being liable to fast updates. Problem is that, 
with the implementation of the new legislation, analytical challenges were faced, 
regarding which methodology to use and the availability and cost of analytical 
standards. With the decree, more than 34000 products that were sold in smartshops in 
Portugal were delivered to the Portuguese police and a protocol was created between 
FCUL and LPC/PJ, with the objective to identify the compounds present in products in 
order to obtain standards for routine analyses. 
Within the scope of this project, two types of products were analysed, plant 
feeders and herbal incenses, known to contain two of the most reported categories of 
NPS, synthetic cathinones and synthetic cannabinoids. 
The methodology applied consists on the identification of these two types of 
products by NMR and EI-MS, allowing them to become secondary standards for 
analyses by GC-MS, as it permits a correct identification of the compounds present 
based not only on mass fragmentation, but also on different Rt for each compound. 
The analysis of 115 samples of plant feeders (8 initial standards, 103 products 
from voluntary deliveries and 4 seized samples) has allowed the construction of an in-
house EI-MS library of 12 synthetic cathinones (3,4-DMMC, 4-MEC, 4F-PBP, 
Buphedrone, Flephedrone, MDPBP, MDPV, Mephedrone, Methedrone, Methylone, N-
ethylcathinone and Pentedrone) plus ethylphenidate. This is a case where the value of 
the developed methodology is shown, as it is rather difficult to distinguish between 
ethylphenidate and methylphenidate merely using GC-EI-MS (with no standards 
available); nevertheless, NMR allowed the correct characterisation of the compound as 
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ethylphenidate. The methodology used and the in-house library allowed the 
identification of a new synthetic cathinone in Europe, 4F-PBP, firstly suggested by MS 
comparison with the secondary standards and then confirmed by NMR analyses. The 
variability studies permitted the study of the qualitative and quantitative variations of 
synthetic cathinone in Portugal, showing no qualitative variance within lot number. Also, 
in the collection “Space Invader”, samples could be organised merely on lot numbers, 
without considering the brand name. An interesting remark is that, of the more of 70 
synthetic cathinones already reported in the EU, only the 12 identified in the in-house 
library could be found in Portuguese powdered plant feeders from 2011 to 2013, plus 
ethylphenidate and caffeine. 
The analysis of 56 samples of herbal incenses has allowed the construction of an 
in-house EI-MS library of 8 synthetic cannabinoids (JWH-018, JWH-122, JWH-210, 
AKB48, UR-144, XLR-11, MAM2201 and SGT-25). The developed methodology also 
allowed the characterisation of a recently reported compound in the EU, SGT-25, not 
yet reported in scientific journals. From the 134 synthetic cannabinoids already reported 
in the EU, only 12 (8 in the EI-MS library plus AM694, Cl-AM694 and AM1248) were 
detected in the 53 herbal incenses samples from Portuguese smartshops from 2013.  
 Concluding, from products of the voluntary deliveries and seized samples an EI-
MS in-house library of NPS consisting of 21 synthetic compounds was created: 12 
cathinones, 8 cannabinoids and ethylphenidate. The construction of this in-house library 
is of great importance for a routine laboratory, as the thorough study of the 
spectrometric and fragmentation behaviour of these compounds may aid in the 
discovery of novel NPS and in the continuous monitoring of already existing 
substances. The advantage of an Rt facilitates the correct identification on these 
compounds.This is very relevant, as, otherwise, these products would have probably 
ended up destroyed, meaning that this methodology allows the avail of street products,   
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6. Appendix 
 
Appendix I - Gaspar, H., Bronze, S, Ciríaco, S., Queirós, C.R., Matias, A., Rodrigues 
J., Oliveira, C., Cordeiro, C. and Santos, S., “4F-PBP: 4F-PBP (4’-fluoro--
pyrrolidinobutyrophenone), a new substance of abuse: structural characterization and 
purity NMR profiling”, Forensic Science International, 252, pp. 168-176, 2015 
 
Highlights 
A new NPS, 4F-PBP was detected and identified for the first time in the EU. 
Analytical data for 4F-PBP are reported for the first time. 
Myo-inositol was found as cutting agent of 4F-PBP. 
A qNMR method was applied to profile cathinones purity. 
Abstract 
The rapidly growing problem of new psychoactive substances (NPS) makes the time 
management for international control a real challenge, with the traditional detection 
methods becoming increasingly inadequate. NPS screening technologies, such as 
NMR, which allows multiple substances to be detected, characterized and quantified 
simultaneously from a single sample, offers a rapid solution to this problem. This study 
describes the application of NMR to the simultaneous detection, characterization and 
quantification of samples of white powders seized by the Portuguese Police. 4F-PBP 
(4′-fluoro-α-pyrolidinobutyrophenone) a new synthetic psychoactive cathinone cut 
with myo-inositol was found in two seized products. The structural characterization of 
4F-PBP was elucidated in the mixture, and confirmed after isolation from the matrix 
by 1H, 13C, 19F NMR and MS. Myo-inositol was found for the first time as a cutting agent 
of cathinones. Furthermore another seized product was characterized as being MDPBP, 
with a high degree of purity, and its spectroscopic elucidation enabled the correction 
of 13C NMR literature assignments. 
Keywords 
Designer drugs; Cathinones; Pyrolidinophenone; 4F-PBP; 
Fluoropyrolidinobutyrophenone; Quantification; NMR 
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Appendix II - Leal, C., Lopes, R., Matias, A., Rodrigues, J. and Gaspar, H., 
“Identification of Synthetic Cathinones in Plant Feeders”, II Jornadas Ibéricas de 
Toxicologia, 13-15 November 2014, Faculdade de Ciências da Saúde, Universidade da 
Beira Interior, Covilhã, Portugal (Poster) 
 In the past few years, there has been an uprising of new psychoactive 
substances (NPS) available in Smartshops and over the Internet. These NPS may be 
masked in herbal mixtures or may be presented as tablets, capsules or in powdered 
forms, being suitable to inhale, smoke, swallow or chew. The sold products often come 
with the caveat of not being for human consumption and are marketed as herbal 
incenses, bath salts or plant feeders. Recently, a new decree has been implemented in 
Portugal (Dec-Lei 54/2013 de 17 de Abril), which forbids the production and 
commercialisation of about 159 NPS, being liable to fast updates, in order to keep up 
with the everyday appearance of new substances. 
The fast appearance of new substances and the lack of adequate analytical 
standards turned the analysis of NPS by forensic scientists into a challenge. This 
project is being developed within the scope of the collaboration between the Faculdade 
de Ciências da Universidade de Lisboa (FCUL) and the Laboratório de Polícia Científica 
da Polícia Judiciária (LPC/PJ), as a result of the need to create effective analytical 
databases that will facilitate the quick identification of these drugs in a forensic context. 
Therefore, the goal of this project is to develop an analytical methodology that allows 
the identification of these substances in different products, even in the absence of 
standards.  
In this context, we started compiling a library of NPS mass spectra from the 
products being sold in the market of drugs of abuse in Portugal. NMR and GC-MS 
analysis of several plant feeder samples allowed the identification of different synthetic 
cathinones, as seen in literature (Araújo et al, 2014 and Zancajo et al, 2014). 
In 29 samples of Blast, Bliss and Blow commercial products in circulation in 
Portugal before the decree, analysed by GC-MS, 5 different compounds have been 
identified. In the future, more compounds will be identified, characterised and added to 
the mass spectra library, so as to allow for the rapid identification of new products that 
may emerge in the still active market of “legal highs”. 
Keywords: NPS; Plant Feeders; NMR; GC-MS  
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Appendix III - Leal, C., Ciríaco, S., Matias, A. and Gaspar, H. “Characterisation of Plant 
Feeders”, 3rd International Meeting on Forensic Science and Criminal Behaviour - 
Globalization of Crime, 8-9 May 2015, Instituto Superior de Ciências da Saúde Egas 
Moniz, Almada, Portugal (Oral) 
In the past years, there has been an uprising of new psychoactive substances 
(NPS) available in Smartshops and over the Internet. These NPS may be presented as 
tablets, capsules or in powdered forms, being suitable to inhale, smoke, swallow or 
chew. The sold products often come with the caveat of not being for human 
consumption and are marketed as bath salts or plant feeders. 
Recently, a new decree has been implemented in Portugal (Dec-Lei 54/2013 de 
17 de Abril), which forbids the production and commercialisation of about 159 NPS, 
being liable to fast updates, in order to keep up with the everyday appearance of new 
substances. 
The fast appearance of new substances and the lack of adequate analytical 
standards turned the analysis of NPS by forensic scientists into a challenge. This 
project is being developed within the scope of the collaboration between FCUL and 
LPC/PJ, as a result of the need to create effective analytical databases that will facilitate 
the quick identification of these drugs in a forensic context. Therefore, the goal of this 
project is to develop an analytical methodology that allows the identification of these 
substances in different products, even in the absence of standards.  
I n this context, we started compiling a library of NPS mass spectra from the 
products being sold in the market of drugs of abuse in Portugal. NMR and GC-MS 
analysis of several plant feeder samples allowed the identification of different synthetic 
cathinones, as seen in literature (Araújo et al, 2014 and Zancajo et al, 2014). 
 This methodology has allowed for the differentiation of compounds with similar 
chromatographic and ionization behaviours, but, more importantly, has allowed the 
identification and characterisation of a new substance, 4F-PBP (4’-fluoro--
pyrolidinobutyrophenone), from samples of white powders seized in Portugal  
 In the future, more compounds will be identified, characterised and added to the 
mass spectra library, so as to allow for the rapid identification of new products that may 
emerge in the still active market of “legal highs”. 
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Appendix IV - Queirós, C., Gonçalves, C., Ciríaco, S., Matias, A., Rodrigues, J. and 
Gaspar, H., “NMR Characterisation of SGT-25: A New Psychoactive Substance”, 19th 
European Symposium on Organic Chemistry, Faculdade de Ciências da Universidade 
de Lisboa, 12-16 July 2015, Lisboa, Portugal (Poster) 
 
In the past few years, there has been an uprising of new psychoactive 
substances (NPS) available in Smartshops and over the Internet. These NPS have 
been separated in different categories, either according to their structure, like synthetic 
cathinones, or according to their biological activity, like synthetic cannabinoids. Over the 
past years, more than 450 new NPS have been reported to the Early Warning System 
by EU Member States. In 2014 alone, more than 100 substances were reported. Up to 
that date, more than 130 of the reported substances were synthetic cannabinoids. 
These compounds are characterised by its affinity to the CB1 and CB2 receptor sites, 
similar to Δ9-THC, the compound present in cannabis. 
Two years ago, a Decree-Law was published in Portugal, which forbids the 
production and commercialisation of about 159 NPS, 46 of which are synthetic 
cannabinoids, being liable to fast updates, in order to keep up with the everyday 
appearance of new substances. 
I n order to circumvent the new legislation, compounds that fall outside the list of 
prohibited substances may arise and their rapid identification is of the uttermost 
importance in forensic laboratories. However, the rapidly growing problem of NPS 
makes the time management for international control a real challenge, with the 
traditional detection methods becoming increasingly inadequate. Nuclear Magnetic 
Resonance (NMR) spectroscopy offers a rapid solution to this problem as it allows the 
identification of a compound, even in a mixture, without the need of the analyte 
standard. Using this methodology we have recently characterised a new synthetic 
cathinone, 4F-PBP and reported it for the first to the European Union Early Warning 
System.  
This study describes the application of NMR in the characterisation of SGT-25 (1-
(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide), a novel ‘third 
generation’ synthetic cannabinoid, from a sample seized in Portugal, which is not part of 
the list of controlled NPS from the new Decree-Law 
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Figure 87 - Chemical Structure of SGT-25 
 This compound was firstly synthesised with the aim to be used as medication in 
animals and humans, due to high affinities for the cannabinoid CB1 and CB2 receptor 
sites. 
The structural characterisation of SGT-25 was elucidated in the seized sample 
and confirmed after isolation using a liquid chromatography system by 1D and 2D NMR 
techniques, in different solvents (CDCl3, benzene (D6), MeOD and DMSO) and also by 
GC-MS. This is a newly detected compound in Portugal and has only recently been 
detected in the EU (first report from November 2014). 
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Appendix V - Leal, C., Gonçalves, C., Matias, A., Rodrigues, J. and Gaspar, H. “Spice 
in Portugal: a source of NPS standards”, 7th European Academy of Forensic Sciences 
Conference, 6-11 September 2015, Prague, Czech Republic (Poster) 
 
In the past few years, there has been an uprising of new psychoactive 
substances (NPS) available in Smartshops and over the Internet. These NPS may be 
masked in herbal mixtures or may be presented as tablets or in powdered forms, being 
suitable to inhale, smoke or swallow. The sold products often come with the caveat of 
not being for human consumption. 
Recently, a new decree has been implemented in Portugal (Dec-Lei 54/2013 de 
17 de Abril), which forbids the production and commercialisation of about 159 NPS, 
being liable to fast updates, in order to keep up with the everyday appearance of new 
substances. The fast emergence of new substances and the lack of adequate analytical 
standards turned the analysis of NPS by forensic scientists into a challenge. 
This project is being developed within the scope of the collaboration between the 
Faculdade de Ciências da Universidade de Lisboa (FCUL) and the Laboratório de 
Polícia Científica da Polícia Judiciária (LPC/PJ), as a result of the need to create 
effective analytical databases that will facilitate the quick identification of these drugs in 
a forensic context in Portugal. 
In this context, 30 herbal incenses available in Portuguese Smartshops in the 
period prior to the legislation were analysed by GC-MS and scanned against existing 
MS spectra databases. From this analysis, 10 synthetic cannabinoids (JWH-210, JWH-
018, JWH-122, JWH-250, MAM2201, AKB48, UR-144, UR-144-cyclopropyl 
rearrangement product, AM-694, AM-1248), one synthetic cathinone (MDPV) and one 
tryptamine (5-MeO-DALT) were identified. 
In order to obtain validated standards for GC-MS analysis, some synthetic 
cannabinoids from the JWH family were isolated through liquid chromatography and 
identified by NMR. This led to the creation of an in-house MS spectra database based 
on retention times and mass fragmentation of the purified compounds. In the future, 
more compounds will be identified, characterised and added to the mass spectra library, 
so as to allow for the rapid identification of new products that may emerge in the still 
active market of “legal highs”. 
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Appendix VI - Gaspar, H., Ciríaco, S., Leal, C., Matias, A., Rodrigues, J. e Santos, S., 
“Tracking NPS: NMR for a rapid identification of new substances”, Lisbon Addictions 
2015, 23-25 September 2015, Lisbon, Portugal (Poster) 
 
In the past years, there has been an uprising of new psychoactive substances (NPS) 
available in “smartshops” and over the Internet. NPS are defined as “new narcotic or 
psychotropic drugs that are not listed in the Single Convention on Narcotic Drugs of 
1961 or the Convention on Psychotropic Substances of 1971, but which may pose a 
public health threat comparable to that posed by substances listed in those 
conventions”. These NPS may be masked in herbal mixtures or presented as tablets, 
capsules or powdered forms, being suitable to inhale, smoke, swallow or chew. The 
sold products often come with the caveat of not being for human consumption and are 
marketed as herbal incenses, bath salts or plant feeders. 
Recently, a new decree has been implemented in Portugal (Dec-Lei 54/2013 de 
17 de Abril), which forbids the production and commercialisation of about 159 NPS, 
being liable to fast updates, in order to keep up with the everyday appearance of new 
substances.The rapidly growing problem of NPS makes the time management for 
international control a real challenge, with the traditional detection methods becoming 
increasingly inadequate. Nuclear Magnetic Resonance (NMR) spectroscopy offers a 
rapid solution to this problem as it allows the simultaneous characterization and 
quantification of compounds from a single sample without the need of chemical 
standards. 
The present work was developed within the scope of the collaboration between 
the Faculdade de Ciências da Universidade de Lisboa (FCUL) and the Laboratório de 
Polícia Científica da Polícia Judiciária (LPC/PJ), and describes the application of NMR 
in the simultaneous detection, characterization and quantification of 4F-PBP (4’-fluoro-
alpha-pyrolidinobutyrophenone), a new designer drug, together with the cutting agent 
myo-inositol, from samples seized in Portugal. The structural characterization of 4F-
PBP was elucidated in the mixture, and confirmed after isolation from the matrix by 
different analytical techniques (1H, 13C, 19F NMR, GC-MS and FTICR). 4F-PBP is a 
newly detected substance in the European Union, reported to the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) for the first time in late January 
(Gaspar et al 2015).The methodology used has proven to be effective for the 
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characterization and quantification of NPS, being a rapid tool for the identification of 
new emerging substances.  
To the authors knowledge, this is the first time that inositol is reported as a 
cutting agent in a seizure of synthetic cathinones and, more importantly, in a very high 
percentage (around 60%). This fact can be a hint that in Portugal, like in other countries, 
after illegalization of this kind of substances, there is a downtrend in the purity of the 
products. This decrease in purity may lead to serious health consequences, with 
unpredictable dangerous effects, since consumers used to products with low purity can 
easily overdose when using a pure sample. 
 
